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ABSTRACT 
BACKGROUND 
The quest for searching newer and safer anaesthetic agents has always been one of the 
primary needs in anaesthesiology practice. Regional anaesthesia techniques have seen numerous 
modifications over the last two decades with the advent of many newer and safer local anaesthetics  
Keeping these factors in mind, S (−)-enantiomer of bupivacaine, levobupivacaine has 
been developed. The advantages of levobupivacaine over bupivacaine are decreased 
cardiovascular toxicity and there is also a relatively decreased motor nerve fiber penetration and 
block, thereby a decreased post operative motor blockade and thus early ambulation of the 
patients can be achieved.  
The present study compared the effects of addition of epidural dexmedetomidine 50 
micrograms to epidural 0.5% levobupivacaine for infraumbilical and lower limb surgeries. 
METHODS 
Sixty patients of either sex belonging to ASA I & II in the age group of 25-45 years 
scheduled for infraumbilical and lower limb surgeries were randomly divided into 2 groups (30 
each)to receive 0.5% isobaric levobupivacaine 20 ml epidurally with 0.5 ml distilled 
water(Group A) and 0.5% isobaric levobupivacaine 20 ml plus 0.5 ml dexmedetomidine 
containing 50 micrograms(Group B). 
This study evaluated the following parameters like time of onset of sensory blockade at 
T10 level, maximum sensory blockade achieved and time taken to achieve the same, onset time 
of motor blockade, degree of motor blockade, time taken to achieve maximal motor blockade, 
hemodynamic changes in pulse rate, blood pressure and oxygen saturation, side effects and 
complications, intraoperative sedation scores, duration of analgesia, sensory & motor blockade, 
and any postoperative adverse reactions. 
           RESULTS 
The data obtained from the above parameters were statistically analysed using SSPS version 16 
software. Student t test was used for parametric data and Chi-square test for non parametric 
data.P<0.05 was  considered as statistically significant. 
  
Maximal sensory level was achieved with addition of dexmedetomidine ranging from T4 
to T6.Also the onset time of motor blockade was shortened with group A showing 19.33 minutes 
and group B showing only 14.5 minutes.The maximal motor blockade achieved was also 
intense(Bromage 3) with the addition of dexmedetomidine. Duration of analgesia, sensory and 
motor blockade were prolonged when levobupivacaine is combined with dexmedetomidine 
epidurally. Changes in hemodynamic parameters (blood pressure & heart rate) were very 
minimal in the dexmedetomidine group. Adverse effects experienced in general were statistically 
insignificant in both the groups. Mean sedation score in group B (Dexmedetomidine group) was 
predominantly found to be 2 as per Ramsay sedation score. None of the patients in group B had 
deep sedation or profound respiratory depression. 
KEYWORDS: Epidural anaesthesia, Levobupivacaine, Dexmedetomidine, infraumbilical 
surgeries, lower limb surgeries. 
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INTRODUCTION 
Regional anaesthesia came in vogue from the time of Sir August Bier in 1898. 
Intrathecal anaesthesia and epidural anaesthesia are the most popular regional 
anaesthetic techniques used for lower abdominal & lower limb surgeries. Regional  
anaesthesia forms an excellent alternative due to its various advantages over general 
anaesthesia including(1) 
1. Awake patient 
2. Polypharmacy avoided 
3. No airway manipulation 
4. Good motor & sensory blockade 
5. Good intra operative and post operative analgesia 
6. Less incidence of post operative nausea and vomiting 
7. Early ambulation and food intake by the patient. 
8. Less incidence of deep vein thrombosis and thromboembolism 
Intrathecal anaesthesia also called as spinal anaesthesia has few limitations 
like shorter duration of anaesthesia (i.e) anaesthesia cannot be maintained for 
prolonged surgeries and troublesome complication of postdural puncture headache 
(PDPH).Major abdominal surgeries may be done by using regional (spinal or 
epidural) or general anaesthesia. Epidural anaesthesia reduces the perioperative stress 
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response to surgery and improves surgical outcome.Epidural anaesthesia and analgesia 
has become one among the best accepted techniques for lower abdominal & lower limb 
surgeries as it provides good sensory and motor blockade with contracted bowels 
retaining adequate spontaneous respiration, hemodynamic stability and also an 
indwelling epidural catheter facilitates further administration of analgesic doses for the 
postoperative period(2). 
Advantages of epidural over spinal anaesthesia being that it (3) 
1. Reduces the incidence of hemodynamic changes due to sympathetic blockade as it 
produces segmental anaesthesia unlike subarachnoid block. 
2. Provides effective surgical anaesthesia for prolonged procedures. 
3. Incidence of postdural puncture headache is not encountered as dura is not pierced. 
4. Provides prolonged postoperative analgesia. 
Lignocaine, a tertiary amide local anaesthetic was synthesised by Nils Lofgren 
in 1943(3).Use of lignocaine for extradural blockade was found to have a greater speed 
of onset and greater degree of both sensory and motor blockade (4). 
But it is also observed that bupivacaine is four times more potent than 
lignocaine and duration of anaesthesia is 2 or 3 times longer than Lignocaine. It has 
excellent prolonged duration of sensory blockade, but muscle relaxation was not 
profound
(5,6) 
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Bupivacaine was synthesised by Ekanstam in 1956 and introduced into clinical 
practice in 1963 by Telivuo. Bupivacaine, the widely used local anaesthetic in regional 
anaesthesia is available in a commercial preparation as a racemic mixture (50:50) of its 
two enantiomers levobupivacaine, S (-) isomer and dextrobupivacaine, R (+) isomer.        
Among the amide local anaesthetics used in regional anaesthetic techniques 
bupivacaine has emerged as the most commonly used drug for central neuraxial 
blockade. Since then bupivacaine is extensively used and has become very popular for 
epidural anaesthesia as well as analgesia because of its long duration of action. Despite 
its undoubted efficacy, bupivacaine is associated with cardiotoxicity and 
neurotoxicity(7,8). 
Severe neurotoxic and cardiovascular adverse reactions reported in the literature 
after inadvertent intravascular injection or intravenous regional anaesthesia have been 
linked to the R(+) isomer of bupivacaine. The levorotatory isomers were shown to have a 
safer pharmacological profile with less cardiac and neurotoxic adverse effects.(7,8)Apart 
from cardiotoxicity,  it also carries undesirable effects like prolonged post operative 
motor blockade. Hence there was a need for introduction of drugs with all the features of 
bupivacaine but having less toxicity profile.(9)  
The quest for searching newer and safer anaesthetic agents has always been one 
of the primary needs in anaesthesiology practice. Regional anaesthesia techniques have 
seen numerous modifications over the last two decades with the advent of many newer 
and safer local anaesthetics (10,11). 
Keeping these factors in mind, S (−)-enantiomer of bupivacaine, 
levobupivacaine has been developed. The advantages of levobupivacaine over 
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bupivacaine are decreased cardiovascular toxicity and there is also a relatively 
decreased motor nerve fiber penetration and block, thereby a decreased post operative 
motor blockade and thus early ambulation of the patients can be achieved(9).  
 It demonstrated  less affinity and strength of depressant effects onto myocardial 
and central nervous vital centres in pharmacodynamic studies and a superior 
pharmacokinetic profile. Reports of toxicity with levobupivacaine are scarce and 
occasional toxic symptoms are usually reversible with minimal treatment with no fatal 
outcome. In anaesthesia and analgesia practice, levobupivacaine and bupivacaine produce 
comparable surgical sensory block but levobupivacaine has the advantage of producing 
less motor blockade. (9) 
The low cardiovascular and neurological toxicity of levobupivacaine has led to its 
varied utility in regional anaesthetic techniques including subarachnoid block, epidural 
anaesthesia and analgesia, brachial plexus blocks as well as local infiltration. It is also 
being used for intraoperative anaesthesia, labour analgesia, and postoperative pain 
management. Both levobupivacaine and ropivacaine are being favoured in labour 
analgesia because of comparable long lasting analgesia, less motor block and less toxicity 
compared to bupivacaine.(12)  
Efforts to find a better adjuvant in regional anaesthesia are underway since long.      
The addition of adjunctive agents (opioids & alpha 2 agonists) to local anaesthetics via 
epidural and intrathecal routes  may provide a dose sparing effect and increase the 
duration and quality of analgesia. (9) 
Opioids like fentanyl have been used traditionally as an adjunct for epidural 
administration in combination with lower dose of local anaesthetic to achieve the desired 
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anaesthetic effect. The addition of opioid does provide a dose sparing effect of local 
anaesthetic and superior analgesia but there is always a possibility of an increased 
incidence of pruritis, urinary retention, nausea, vomiting and respiratory depression. (9) 
The pharmacologic properties of alpha 2 agonist have been extensively studied 
and have been employed clinically to achieve desired effects in regional anaesthesia. 
Clonidine is an alpha-2 adrenergic agonist which, when administered by epidural 
route, has analgesic properties and potentiates the effect of local anaesthetics. 
Clonidine is 200-folds more selective for alpha-2 as compared to alpha-1. 
Dexmedetomidine is a new addition to the class of alpha 2 agonists which has got 
numerous beneficial effects when used through epidural route. It acts on both pre and post 
synaptic sympathetic nerve terminals and central nervous system, thereby decreasing the 
sympathetic outflow and nor epinephrine release causing sedative, anti-anxiety, analgesic, 
sympatholytic and hemodynamic effects.(13) 
Dexmedetomidine, made up of medetomidine’s dextrogyrous enantiomer,is 
currently considered a super selective alpha-2 adrenergic agonist prototype and is 
1600-folds more selective for alpha-2  receptor. Dexmedetomidine is a highly selective 
alpha 2 adrenergic agonist with greater  receptor affinity than clonidine.(9) In addition it 
also has hemodynamic stabilising effects and reduction of anaesthetic drug requirements. 
Epidural dexmedetomidine does cause a manageable hypotension & bradycardia but the 
striking feature of this drug is its lack of opioid related side effects like respiratory 
depression, pruritis, nausea and vomiting. (14)  
Hence the present study is to evaluate the effects of addition of dexmedetomidine 
to epidural 0.5% levobupivacaine in infraumbilical and lower limb surgeries.  
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AIM OF THE STUDY 
The aim of the present study is to evaluate the effect of addition of 
Dexmedetomidine to epidural  0.5% Levobupivacaine solution on the 
 1. Time of onset of sensory blockade at T10 level 
2. Maximum sensory blockade and time taken to achieve that level 
3. Onset of motor blockade 
4. Degree of motor blockade achieved 
5. Haemodynamic changes in the pulse rate & blood pressure 
6. Side effects and complications 
7. Intraoperative sedation scores 
8. Duration of analgesia 
9. Duration of sensory blockade 
10. Duration of motor blockade 
11. Any postoperative untoward reactions     
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ANATOMY OF THE VERTEBRAL COLUMN (15) 
Knowledge of the anatomy of vertebral column is of particular importance to 
anaesthesiologists. There are 
7  Cervical vertebrae  
12  Thoracic vertebrae  
5  Lumbar vertebrae  
5  Sacral vertebrae (Fused)  
4  Coccygeal vertebrae (Fused)  
The cervical and lumbar curvatures are convex anteriorly while, thoracic and 
sacral curvatures are convex posteriorly.  
 
 
 
 
 
FIGURE 1: ANATOMY OF VERTEBRAL COLUMN 
A typical vertebra has two parts:  
1. anteriorly, BODY or the base which bears the weight.  
2. The ARCH surrounds the cord laterally and posteriorly consists of lamina and 
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pedicles.  
3. There are seven processes or projections:  
 a. Three muscular processes - two transverse and one spinous.  
 b. There are four articular processes - two upper and two lower.  
The typical thoracic vertebra:  
It has a heart-shaped body bearing one or two facets for articulating with the 
head of a rib. Its vertebral foramen is smaller and circular than those of the cervical 
and lumbar regions.  
The two pedicles bear long and strong transverse processes. It articulates with 
the neighbouring vertebra by means of articular processes that bear vertical facets 
superior facing posteriorly and inferior facing anteriorly. Its spinous process is long 
and slopes posteroinferiorly so that the tip overlies the level of the vertebral body 
below.  
FIGURE 2: THORACIC VERTEBRA 
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The typical lumbar vertebra  
It has a larger kidney-shaped body and its vertebral foramen is larger when 
compared to that of thoracic vertebra. Its transverse processes are long and slender. Its 
articular processes are directed (superior) posteromedially and (inferior) 
anterolaterally. Its spinous processes are shorter, broader and more horizontal than 
those of thoracic vertebrae.  
 
 
 
 
FIGURE 3: LUMBAR VERTEBRA 
Intervertebral disc  
These are the connecting links between the vertebral bodies and they account 
25% of the length of spine. Each disc adheres above and below to the hyaline 
cartilage which covers the facet of adjacent vertebral body in front and behind and the 
disc also gets attached to the anterior and posterior longitudinal ligaments.  
Joints of the vertebral column  
The vertebrae articulate at the intervertebral and facet joints. The intervertebral 
joints are located between adjacent vertebral bodies. They maintain the strength of 
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attachment between vertebrae. The facet joints lie between superior and inferior 
articular processes.  
Contents of vertebral canal:  
1. Spinal cord and meninges.  
2. Cerebrospinal fluid.  
3. Spinal nerve roots.  
4. Vessels, areolar tissue.  
SPINAL CORD:  
Medulla oblongata continues as spinal cord below the level of foramen 
magnum  tapering off into conical extremity known as conus medullaris. From the 
apex of conus medullaris, delicate fibrous filaments descend into the back of first 
segment of coccyx, which is called as filum terminale. At birth, the spinal cord ends at 
the level of lower border of third lumbar vertebra. In adults the level of termination of 
spinal cord may be as follows:  
• Lower border of L1 vertebra 50%  
• Upper border of L2 vertebra 40%  
• Lower border of L3 vertebra 10% 
THE MENINGES 
Dura mater: It is the outer most and thickest meningeal tissue. It begins at the 
foramen magnum, where it fuses with the periosteum of the skull. The dural sac of 
spinal dura mater is the continuation of the cranial dura mater. It is a circular sac or 
sleeve surrounding the spinal cord. Caudally it ends at S2 where it fuses with filum 
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terminale. It extends laterally along the spinal nerve roots to become continuous with 
the connective tissues of the epineurium at the level of intervertebral foramina. The 
dura mater is composed of randomly arranged collagen fibres along with longitudinally 
and circumferentially arranged elastin fibres. It is largely acellular except for a single 
layer of cells that forms the border between the dura and arachnoid mater. Despite the 
lack of cellular elements, the inner edge is highly vascular, due to which it forms an 
important route for drug clearance from epidural and subarachnoid space. The inner 
surface of the dura mater abuts the arachnoid mater. There is a potential space 
between these two membranes called subdural space. Occasionally it is possible to 
inadvertently insert an epidural catheter into the subdural space.  
 Lower extent of dural sac can be as follows: 
S2 vertebra -35%  
Below S2- 40%  
Above S2- 25%  
Below this the dura continues as the covering of filum terminale.  
Arachnoid mater: It is a delicate, avascular membrane composed of overlapping 
layers of  flattened cells with connective tissue fibres running between the cellular 
layers. These cells are interconnected by frequent tight junctions and occluding 
junctions, which account for the fact that arachnoid mater acts as the main barrier for 
drugs moving between the epidural space and spinal cord. Superiorly the spinal 
arachnoid continues with the cranial arachnoid and inferiorly it ends along with dura at 
the lower border of S2. Arachnoidmater herniates through the dura into the epidural 
space near the spinal nerve roots forming arachnoid granulations. These granulations 
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serve as exit for the drugs from subarachnoid space. The subarachnoid space lies 
between arachnoid and pia mater and contains CSF.It is in continuity with cranial CSF 
and provides route for the drugs to reach brain. 
Pia mater: It is also a delicate, highly vascular membrane which adheres intimately to 
the spinal cord and dips into the long sulci along its surface. It consists of a thin layer 
of connective tissue cells interposed with collagen. There are trabeculae which connect 
the piamater with arachnoid mater and the cells of these two meninges blend together 
along the trabeculae.Fenestrations in pia mater help in communication with the 
subarachnoid space. Pia forms a separate sheath for each nerve rootlet as far as the 
intervertebral foramina, where it binds with the epineurium. At the lower end of the 
cord, pia continues as a thin thread the filum terminale which becomes invested by the 
dural (external) filum terminale and continues to the coccyx. Considered an extension 
of piamater, the delicate ligament is much tougher and less vascular than that of pia. 
These are attached to the dura by a series of 20-21 meticulous processes (tooth like 
projections) which aid in the supporting the spinal cord.  
 
 
 
 
 
FIGURE 4: MENINGES 
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Spinal segments 
The spinal cord is divided into segments by means of spinal nerves arising from it. 
The spinal nerves are 31 in number and are as follows:-  
8  Cervical  
12 Thoracic  
5 Lumbar  
5 Sacral  
1          Coccygeal (rudimentary)  
The nerve roots within the dura have no epidural sheath. Therefore they are 
easily affected by doses of analgesic drugs brought into contact with them.  
Spinal nerves 
Two roots, anterior and posterior fuse together forming spinal nerves. 
Sympathetic preganglionic fibres arise from cells in the intermediolateral horn of the 
spinal cord from T1 to L2. The posterior root is larger than the anterior and the 
efferent impulses from whole body including viscera pass through these roots. Each 
posterior root has a ganglion which conveys afferent impulses of touch, pain, 
temperature, deep sensation from joints, muscles and tendons as well as afferent 
impulses from viscera. 
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FIGURE 5: CROSS SECTION OF SPINAL NERVE 
Segmental levels 
1. Perineum S1- S4  
2. Inguinal region L1  
3. Umbilicus T10  
4. Subcostal T6-9  
5. Nipple line T4-5  
6. Second intercostal space T2  
7. Clavicle C3-4  
The skin above the nipple has double innervations from C3-4 and T 2, 3, 4. So 
even with a successful block to C8 there will be some sensation above the nipple line. 
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Blood supply of spinal cord 
The principle arterial supply of the spinal cord is derived from one anterior and 
two posterior spinal arteries which descend from the level of foramen magnum. The 
anterior spinal artery is formed by the union of branches from each vertebral artery at 
the foramen magnum. It supplies anterior 2/3 of the spinal cord. There are two 
posterior spinal arteries, one on each side. They are derived either directly from the 
vertebral artery or more often from a primary branch of each vertebral artery. They 
supply the posterior 1/3rd of the spinal cord. This supply is augmented by spinal 
branches of the vertebral, ascending cervical, posterior intercostals, lumbar and lateral 
sacral arteries, which also pass through the intervertebral foramina. Venous drainage is 
via a plexus of anterior and posterior spinal veins in the neck, the azygous vein in 
thorax, lumbar veins in the abdomen and lateral sacral veins in the pelvis. 
 
FIGURE 6: BLOOD SUPPLY OF SPINAL CORD 
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ANATOMY OF EPIDURAL SPACE(16,17) 
The epidural space is a circular space surrounding the dura which extends from 
foramen magnum to the coccyx. The lower limit is sacrococcygeal membrane. The 
space is potential and exists between the lining of the vertebral canal and the dural sac. 
Structures encountered from skin to the epidural space by the advancing epidural 
needle in midline approach are:  
1. Skin  
2. Subcutaneous tissue  
3. Supraspinous ligament  
4. Interspinous ligament  
5. Ligamentum flavum  
Ligaments  
a. Supraspinous ligament runs superficial to the spinous processes  
b. Posterior spinous processes are connected by Interspinous ligament  
c. Laminae are connected by Ligamentum flavum  
Supraspinous ligament  
It is a strong fibrous cord that connects the apices of the spinous processes 
from the sacrum to C7, where it continues as ligamentum nuchae. It is thickest and 
broadest in the lumbar region and varies with age, sex and body built.  
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Interspinous ligament  
It is a thin membranous ligament that connects the spinous processes blending 
anteriorly with the ligamentum flavum and posteriorly with the supraspinous 
ligaments. Like supraspinous ligaments, the interspinous ligaments are thickest and 
broadest in the lumbar region.  
 
FIGURE7:LIGAMENTS 
Ligamentum flavum 
It comprises of yellow elastic fibers and connects adjacent laminae that run 
from the caudal edge of the lamina above to the cephalic edge of the lamina below. 
Laterally, this ligament begins at the roots of the articular processes and extends 
posteriorly and medially to the point where the laminae join to form the spinous 
process. Hence the two components of the ligament are limited, thus covering the 
interlaminar space. Because of its elasticity and its thickness of several millimetres in 
the lumbar region, the ligaments impart a characteristic 'springy' resistance, 
particularly to large bore needle with an upturned end [Tuohy needle]. The ligament 
thickness, distance to dura and skin to dura distance vary with the area of vertebral 
canal.  
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FIGURE 8: LIGAMENTUM FLAVUM 
Table: 1 Thickness of ligamentum flavum at different levels(18) 
Level Thickness 
Cervical 1-2 mm 
Thoracic 3-5 mm 
Lumbar 5-6 mm 
Caudal 2-6 mm 
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BOUNDARIES OF THE EPIDURAL SPACE 
Superior: The foramen magnum. The two layers of the dura mater are attached to      
the margins of the foramen magnum.  
Inferior: Sacral hiatus and the sacrococcygeal membrane.  
Lateral: Periosteum of the pedicles and the inter-vertebral foramina.  
Anterior: Posterior longitudinal ligament covers the vertebral bodies and the 
intervertebral discs.  
Posterior: The anterior surfaces of the laminae and their connecting ligaments, roots 
of the vertebral spines and the ligamentum flavum. 
CONTENTS OF THE EPIDURAL SPACE 
Dural sac and the spinal nerve roots.  
Epidural plexus of veins.  
Epidural fat.  
Lymphatics.  
Spinal arteries.  
Epidural fat 
It consists of  semifluid lobulated areolar tissue. It is most abundant 
posteriorly, diminishes adjacent to the articular  processes, and increases laterally 
around spinal nerve roots, where it is continuous with the fat surrounding the spinal 
nerves in the intervertebral foramina and hence with the fat in the paravertebral space. 
Overall the amount of fat in the epidural space tends to vary in direct relation to that 
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present elsewhere in the body, so that obese patients may have epidural spaces that 
are occupied by generous amount of fat. The fat itself has a great affinity for drugs 
with high lipid solubility, which may remain in epidural fat for longer periods. 
Uptake of local anaesthetics into epidural fat competes with vascular and neural 
uptake.  
Epidural veins 
The large valveless epidural veins are part of the internal vertebral venous 
plexus, which drains the neural tissue of the cord, the CSF and the bony spinal canal. 
The major portion of this plexus lies in the anterolateral part of the epidural space. The 
plexus has rich segmental connections at all levels within the intervertebral 
foramina, epidural space and within the body of the vertebrae. Superiorly, the plexus 
communicates with the occipital, sigmoid and basilar venous sinuses within the 
cranium. Inferiorly, anastomosis by way of the sacral venous plexus links the 
vertebral plexus to uterine and iliac veins.  
By way of intervertebral foramina at each level, the vertebral plexus 
communicates with the thoracic and abdominal veins, so that pressure changes in 
these cavities are transmitted to epidural veins but not to the supporting bony 
elements of the neural arch and vertebral bodies. Thus, marked increase in intra 
abdominal pressure may compress the inferior vena cava while distending the 
epidural veins, increasing flow upto the vertebrobasilar plexus. This increased flow 
is accommodated mostly by means of the azygous vein, which ascends in the right 
chest over the root of right lung into the superior vena cava. Distension of epidural 
veins, owing to direct inferior vena cava obstruction [as in pregnancy] or owing to 
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increased thoracic and abdominal pressure, will also diminish the effective volume 
of the epidural space, with the result that injected local anaesthetic spread more 
widely up and down the epidural space.  
Three important aspects of safety Include:   
1. The epidural needle should pierce the ligamentum flavum in the midline to avoid 
the laterally placed epidural veins.  
2. Insertion of epidural needles or catheters or injections of local anaesthetics should 
be avoided during episodes of marked increase in size of epidural veins, such as  
during straining in labour.  
3. The presence of venacaval obstruction calls for a reduction in dose, a decreased  
rate of injection and increased care in aspirating blood before epidural injection.  
Spinal arteries  
It is of significance to epidural block that the spinal branches of the 
subclavian, aortic and iliac arteries  enters the epidural space in the region of the dural 
cuffs. The anterior spinal artery territory supplying the anterior horn or motor area of 
the spinal cord is the most vulnerable as it is a single artery and does not anastomose 
with the two posterior spinal arteries.  
Epidural lymphatics 
The dural cuff region is supplied with rich lymphatic network that rapidly 
conveys debris from arachnoid villi out through intervertebral foramina to reach 
lymph channels in front of the vertebral bodies.  
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Dural sac  
Encases dura, arachnoid, spinal fluid, pia, spinal nerves and spinal cord. 
Epidural pressure  
In the lumbar region, the major cause of generation of a negative pressure lies 
in coning of the dura by the advancing needle point. Negative pressure increases as 
the needle advances across the epidural space towards the dura. Blunt needles with 
side openings produce the greatest negative pressure; they produce a good coning 
effect on the dura without puncturing it and transmit the negative pressure well 
because of their side opening.  
Slow introduction of the needle produces the greatest negative pressure.  
Greatest negative pressure can be obtained if the dura is not distended [eg. By gravity 
in sitting position or by high abdominal or thoracic pressure]. In pregnancy, the 
epidural space may well have a positive pressure. Hence hanging drop technique may 
not be reliable in pregnant women to identify the epidural space.  
Table: 2 Thickness of epidural space at different levels(18) 
Levels Thickness(mm) 
Cervical 2-3 
Thoracic 3-5 
Lumbar 5-6 
Sacral 2-6 
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HISTORY OF EPIDURAL ANAESTHESIA 
History of epidural and intrathecal anaesthesia and analgesia has been in parallel 
with the development of general anaesthesia. As ether anaesthesia (1846) is considered 
the first modern anaesthetic since its use by Morton 162 years ago, so also was August 
Bier, the first to introduce intrathecal anaesthesia by using cocaine in 1898. The discovery 
of the local analgesic effect of cocaine by Carl Koller in 1884 made possible the vast 
array of   regional analgesic therapy. (19) 
Interspinous approach to the epidural space was first introduced by Pages in 
1921
(20) and further popularized by Dogliotti in 1951
(21)
.Next important development 
was the adaptation of Tuohy’s catheter technique in 1945 for continuous spinal 
anaesthesia by Tuohy (22) and epidural anaesthesia by Curbello (23) in 1949.Advantages 
of epidural anaesthesia is that a single injection will provide perioperative analgesia, 
muscular relaxation, graded hypotension and decreased blood loss. 
The first epidural injection was introduced by Jean Athanase Sicard, a French 
neurologist and Cathelin FC in 1901.Sicard also described “loss of resistance”technique 
for locating the epidural space in 1921.Lumbar epidural technique was first performed by 
Fidel Pages of Spain in1921 for abdominal surgeries.(20) 
A.M.Dogliotti,(21) an Italian surgeon has been considered the father of modern 
epidural anaesthesia. He described in detail the anatomy and physiology of epidural space 
and developed the modern “loss of resistance”technique for clinical location of epidural 
space (18) in 1932. Gutierrez taking advantage of the negative pressure in epidural space 
described the “sign of drop”. 
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EPIDURAL NEEDLES 
In 1944, Tuohy used 15 G Barker needle through which no.4 ureteric silk catheter 
was passed into subarachnoid space. (22).A Seattle dentist Huber RL, invented hypodermic 
needle with a long, sharp and curved tip to lessen the pain on injection. Tuohy recognised 
that this curved tip (Huber point) would facilitate placement of epidural catheter and 
applied this design to his needle in 1945.He also added a stylet to decrease the risk of skin 
plugging.(22,24) 
In 1954 Hustead introduced epidural needle with a rounded heel to reduce the 
danger of trapping the catheter. Weiss was practising hanging drop method for locating 
epidural space. He introduced metal wings to the hub of the epidural needle. In 1987, 
Sprotte introduced pencil point epidural needle, to minimise tissue trauma. (25) 
EPIDURAL CATHETERS 
The first indwelling catheter to be used for continuous epidural anaesthesia was 
silk 3.5 to 4F ureteric catheters. Flowers in 1949 described the use of plastic catheters. 
First material to be used was polyethylene, which was replaced by polyvinylchloride 
(PVC).Recently nylon, Teflon, polyurethane and silicone materials are being used to 
produce thin, yet kink resistant catheter with good stiffness and tensile strength. 
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PHYSIOLOGY OF EPIDURAL ANAESTHESIA (1) 
Originally negative extradural pressure was described in 1928 by Heldt and 
Moloney. This so called negative pressure in the peridural space is greatest at points of 
firm attachments. It is also greatest in the thoracic region, less in the lumbar region and 
least in the sacral area. 
Possible causes of negative pressure in the epidural space include:  
1. CONE THEORY: Dimpling / coning of dura by the advancing needle.  
2.TRANSMISSION THEORY: Transfer of negative pressure from thorax 
(transmission of negative intrapleural pressure into the peridural space).  
3. The initial bulge of the yellow ligament, in front of the advancing needle followed 
by its rapid return to the resting position once the needle has perforated the ligament.  
 
 
 
 
 
 
FIGURE 9: NEGATIVE PRESSURE IN EPIDURAL SPACE 
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Identification of Epidural space 
Loss of resistance method:  
1. Syringe technique  
2. Spring loaded technique  
3. Balloon technique (Macintosh's epidural space indicator)  
4. Brooks device  
5. Vertical tube of Dawkin 
Negative pressure technique  
1. Hanging drop sign  
2. Capillary tube method  
3. Manometer technique  
Others  
1) Ultrasonic localization  
2) Oxford epidural space indicator  
Newer techniques  
1) Auditory amplification method  
2) Doppler guidance  
3) Pressure transducer guided method  
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Factors affecting epidural anaesthesia 
1. Site of injection  
After lumbar injection, analgesia spreads to a greater extent, cranially, with a 
delay at the L5 and S1 segments, due to larger size of these nerve roots.  
After thoracic injection, analgesia spreads evenly from the site of injection. 
The upper thoracic and lower cervical roots are resistant to blockade due to their 
larger size. The epidural space in the thoracic region is usually smaller and a lower 
volume of local anaesthetic is needed.  
2. Age, height & weight 
There is an age related decrease in the size and compliance of the epidural 
space due to which there is a decrease in the volume of local anaesthetic needed to 
achieve a given level of block. The patient's height correlates to some extent with the 
volume of local anaesthetic needed, so that shorter individuals need lower volume of 
local anaesthetic i.e. 1 ml per segment to be blocked, while volumes up to 2 ml per 
segment may be required in case of taller individuals. The safest approach is to inject 
incremental doses and monitor the effect carefully.There is little correlation between 
the weight of the patient and the volume of local anaesthetic needed, but in morbidly 
obese patients the epidural space may be narrowed due to the increase in intra-
abdominal pressure, and hence a smaller volume of local anaesthetic is needed.  
Furthermore, epidural venous engorgement due to compression of the azygous 
venous system may further reduce the size of the epidural space, and increase the risk 
of puncture of an epidural vein. The same applies to patients with large intra-
abdominal tumours, ascites, and in pregnancy after 28 weeks.  
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3. Dosage  
The dosage required for analgesia or anaesthesia is determined by several 
factors but usually, 1-2ml of local anaesthetic is needed per segment to be blocked. 
The spread of local anaesthetic inside the epidural space is unpredictable as its size is 
variable, as is the amount of local anaesthetic that leaks into the paravertebral space. 
The dosage is a function of the volume injected and the concentration of the solution 
used and so the response need not be the same if similar dose is used in a different 
volume and concentration. A higher volume of local anaesthetic with low 
concentration will result in a large number of segments to be blocked but with less 
dense sensory and motor blockade.  
It is important to remember that sympathetic fibres having the smallest 
diameter are the most easily blocked. Even with low concentrations of local 
anaesthetic the degree of sympathetic blockade is related to the number of segments 
blocked.  
With an epidural catheter, slow incremental dosing is possible which is 
important in preventing excessively high sympathetic blockade associated with 
hypotension. The need for "top-up" doses of local anaesthetic is dependent on the 
duration of action of the drug. Repeat doses should be given before the block could 
regress to the extent so that the patient does not experience pain. A useful concept is 
the "time to two-segment regression". This is the time taken from injection of the first 
dose of local anaesthetic till the time when the maximum sensory level has receded by 
two segments. When two segment regression has occurred, one half of the original 
dose should be injected to maintain the block. The time taken for two-segment 
regression in case of lignocaine is 90-150 minutes, and for bupivacaine it is 200-260 
minutes.  
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4. Vasoconstrictors  
• Although the addition of vasoconstrictors to local anaesthetics prolongs anaesthesia 
with other regional techniques, their effects on epidural anaesthesia is less consistent.  
• With bupivacaine, the addition of epinephrine has not been shown to prolong 
anaesthesia while with lignocaine the addition of adrenaline (usually 1:200000) 
prolongs the duration of  action of lignocaine.  
• However, vasoconstriction does reduce the amount of systemic absorption of local 
anaesthetics, and reduces the risk of toxicity. 
5. Posture  
The effect of gravity during placement of the epidural technique has an effect on the 
spread of local anaesthetic with the caudad area getting blocked with more intensity.  
6. Alkalinisation of local anaesthetics 
Commercially available solutions of local anaesthetics have a pH between 3.5 and 5.5 
for  chemical stability and bacteriostasis. Most local anaesthetics are weak bases and 
exist in  ionised (hydrophilic) form at this pH. Since neural blockade depends on the 
penetration of the drug into lipid nerve cell membranes, the non-ionised (lipophilic) 
form of the drug crosses the lipid membranes more easily. It follows that by increasing 
the pH of the solution, the proportion of drug in the non-ionised form increases and 
thus neural penetration is enhanced which in turn speeds up the onset of blockade. The 
addition of 8.4% sodium bicarbonate (0.5ml per 10ml of local anaesthetic solution) 
helps to achieve more rapid onset of blockade.  
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7. Number and frequency of local anaesthetic  injections 
Whether augmentation or diminution of neural blockade occurs after repeated 
epidural injection of local anaesthetics depends on the local anaesthetic agent, the 
number of injections and timing between injections. Tachyphylaxis has been most 
clearly demonstrated in association with continuous epidural block in patients in 
whom repeated injections of the short acting amides - lidocaine, prilocaine or 
mepivacaine are used. The mechanism of  tachyphylaxis is not known. It may be 
partly explained by pH changes in spinal fluid  with repeated injections.  
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PHYSIOLOGICAL EFFECTS OF EPIDURAL BLOCKADE(26) 
Epidural blockade implies sympathetic blockade accompanied by somatic 
blockade, which  may involve sensory and motor blockade alone or in combination. 
Some of the most  important physiological effects of epidural blockade can be 
discussed  in relation to either sympathetic blockade of vasoconstrictor fibers below 
T4 and or of cardiac sympathetic fibers.  
Zone of differential blockade 
Sensory  
In intradural block sympathetic fibers are blocked two or three segments 
higher than sensory fibers. In extradural block, the relationship is complex. Level of 
sympathetic block is the same as (or lower than) sensory with epidural blockade. 
Sympathetic block will be greater when more concentrated solutions are used or when 
Adrenaline is added..  
Motor  
In intradural block, the difference between sensory and motor block is two  
segments. In extradural block, the difference in levels is greater, depending very much 
on the  nature of local analgesic solution. All types of nerve fibers are affected by local 
anaesthetics, but there is tendency for small, slower conducting fibers to be more 
readily blocked than large, fast conducting fibers. Between fiber types however, these 
rules do not hold good. Myelinated preganglionic B fibers which have a faster 
conduction time are about three times more sensitive to local anaesthetics than the 
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slower non- myelinated post ganglionic C fibers.  
Sensory A fibers appear to be more sensitive to blockade than motor A 
fibers, although of the same conduction velocity, this may be because sensory fibers  
conduct at a higher frequency. It has been suggested that this selectivity for sensory 
fibers exhibited by Bupivacaine and Ropivacaine is a function of frequency 
dependent block, a property not shared by Etidocaine and Amethocaine.  
Cardiovascular System 
These are the different ways in which extradural block can influence the 
cardiovascular system. . 
1.Vasodilatation of resistance and capacitance vessels. Block of cardiac efferent  
sympathetic fibers from T1 to T4 resulting in loss of chronotropic and Inotropic  
drive and fall in cardiac output.  
2. The arterial or Bainbridge reflex causing-bradycardia.  
3. The operation of Marey's law causing tachycardia.  
4. Depression of vascular smooth muscle and  adrenergic blockade of myocardium   
with fall in cardiac output.  
5. Adrenaline effect (if used) following absorption, results in  stimulation and 
associated rise in cardiac output and reduction in peripheral resistance. Corrective 
measures may be considered if arterial pressure falls more than 1/3 below  its pre-
operative level. Slowing of  heart rate is caused if any of the anterior roots carrying 
sympathetic cardiac accelerator fibers are blocked, as may happen in higher spinal 
blockade above  T4, T5. A further cause of slow pulse rate is the lowering of blood 
pressure in the right atrium consequent to diminished venous return [Bainbridge 
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(1874-1921) effect].  
On the other hand, Tachycardia during spinal analgesia may result from the 
operation  of Marey's Law (a pulse of low tension is fast). Bradycardia is the more 
frequent effect.  
Theories of causation of fall in blood pressure  
1. Diminished cardiac output consequent to reduction of venous return to heart, and 
lack of muscular propulsive force on veins.  
2. Dilatation of post arteriolar capillaries and small venules due to paralysis of 
Vasoconstrictor fibres. Compensatory vasoconstriction takes place in areas not 
anaesthetized via carotid sinus reflexes.  
3. Paralysis of sympathetic nerve supply to heart T1-T4. Bradycardia may give rise  
to fall in cardiac output.  
4. Paralysis of sympathetic nerve supply to the adrenal glands, with consequent 
catecholamine depletion  
5. Absorption of drug into circulation. This is more likely to be a cause of 
hypotension after extradural than after intradural analgesia because of the large 
amount of analgesic drug injected.  
6. Ischemia and  hypoxia of vital centers  
7. Hypovolemia, if present, may give rise to fall in blood pressure if central neural  
blockade is employed.  
8. Compression of great vessels within abdomen, by the pregnant uterus, abdominal 
tumours or abdominal packs may cause severe hypotension in presence of central 
neural blockade.  
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Respiratory system 
The phrenic nerve supplying diaphragm arises from the anterior roots of C3, 
C4, C5 and should not be encroached on in spinal anaesthesia, but phrenic nerve 
paralysis can occur.  
Apnoea may be due to medullary ischemia or due to toxic effect of the drug in 
extradural blocks. During spinal analgesia breathing becomes quite and tranquil. This 
is not only due to motor blockade, but also due to  reduction of sensory input to 
respiratory centre. Lowered arterial and venous tone also lessens the work of heart 
and tends to relieve any pre existing pulmonary congestion. The ventilation 
perfusion during extradural block is not greatly altered and effects on respiratory 
functions are relatively small with no evidence of changes in FRC or V/Q ratio. The 
pulmonary gas exchange is preserved.  
 Vital capacity and forced expiratory volume may be reduced, especially in 
cigarette smokers. Intercostal muscle paralysis is compensated for by descent of 
diaphragm, which is made easier  by the lax abdominal walls. This is not 
accompanied by hypoxia and hypercapnia although the ability to cough forcibly to 
expel secretion is impaired. The patient may become apnoeic so that tracheal 
intubation is required. Causes may be:  
 Inadequate medullary blood flow due to inadequate cardiac output-a serious 
situation demanding immediate cardiorespiratory support.  
 Total spinal anaesthesia with denervation of all respiratory muscles. True 
phrenic nerve paralysis is uncommon because all motor nerve roots are large 
and the anaesthetic solution is likely to be weak when it reaches the cervical 
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region.  
 Accidental subdural injection   
 Toxic effects of local analgesic drug. 
 Injecting narcotic analgesic drugs  
Gastrointestinal system  
Preganglionic sympathetic fibers from T5 to L1 are inhibitory to gut. There is 
no effect on oesophagus, the innervation of which is vagus. The small gut is 
contracted as the sympathetic inhibitory impulses are removed, the vagus being all 
powerful, sphincters are relaxed and peristalsis is active. Pressure within the bowel 
lumen is increased.  
Nausea and vomiting due to  hypotension may occur and usually come on in 
waves-lasting a minute or so and then passing away spontaneously. Stimuli arising in 
the upper abdomen may ascend along the unblocked vagi and perhaps the phrenic 
nerve, and cause discomfort, if the patient is conscious. Infiltration of local anesthetic 
solutions may prevent this by blocking vagal afferents. Colonic blood supply and 
oxygen availability are increased, perhaps an important factor in the prevention of 
anastomotic breakdown following gut resection.  
Theories of causation of nausea and vomiting:  
1. Hypotension-correction using a pressor drug may relieve nausea  
2. Increased  peristalsis  
3. Traction on nerve endings and plexuses, especially via vagus  
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4. Presence of bile in stomach due to relaxation of pyloric and bile-duct sphincters  
5. Narcotic analgesics (premedication)  
6. Psychological factors  
7. Hypoxia  
Gastric emptying time is quicker when extradural block is employed for 
postoperative pain relief than when narcotic analgesics are used.  
Liver  
There are no specific effects of significance. The degree of hypotension that 
compromises liver function is not known. Liver disease may interfere with the 
metabolism of local anaesthetic drugs.  
Endocrine system  
The usual increase of anti diuretic hormone (ADH) during surgery is 
suppressed. Spinal block delays adrenal response to trauma, whereas surgeries under 
general anaesthesia cause a rise in steroids. In any case, either regional or general, 
there is no difference in the postoperative period once the effect of the block wears 
off. Spinal block suppresses the hyperglycemic response to surgery and stress and so 
is useful in diabetic patients but this does not extend into postoperative period. The 
response to insulin is augmented and anaesthetist should be aware of the possibility of 
hypoglycemia.  
Extradural block prevents lymphopenia and granulocytosis after surgery, thus 
inhibiting the metabolic endocrine response to surgery and thereby preventing  
immune suppression.  
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Genito urinary system  
Sympathetic supply of kidney is from T11 to L1 via the lowest splanchnic 
nerves. Any effects on renal function are due to hypotension. Auto regulation of  renal  
blood flow is impaired if mean arterial pressure falls below 50 mmHg. These changes  
are transient and disappear when blood pressure rises again.  
Sphincters of bladder are not relaxed and tone of ureters is not greatly altered. 
The penis is often engorged and flaccid due to paralysis of the Nervi erigentes [S2 and 
S3]. This is a useful positive sign of successful block. Post spinal retention of urine 
may be moderately prolonged as L2 and L3 contain small autonomic fibers and their 
paralysis lasts longer than that of the larger sensory and motor fibers.  
Body temperature  
Vasodilatation favours heat loss. Absence of sweating favors hyperpyrexia in hot 
environments. Catecholamine secretion is depressed, hence less heat is produced  
by metabolism.  
Extradural space is a temperature sensitive zone, whereas intradural space is not. Cold 
solutions injected into extradural space may induce shivering    
1. Because the large veins act as exchangers.  
2. As a result of sensory input.  
3. Possibly because of the existence of thermal sensors. 
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PHARMACOLOGY- LEVOBUPIVACAINE 
Classification of Local anaesthetics 
Local anaesthetic agents consist of a lipophilic group(usually an aromatic 
benzene ring) separated from a hydrophilic group(usually a tertiary amine) by an 
intermediate chain that includes an ester or amide linkage.The amino ester group have 
an ester link and include cocaine, procaine, chloroprocaine and tetracaine. The amino 
amides have an amide link between the aromatic head and the intermediate chain and 
include lignocaine, bupivacaine, dibucaine,mepivacaine, prilocaine, etidocaine, 
ropivacaine and levobupivacaine. (26) 
LEVOBUPIVACAINE (12) 
CHEMICAL STRUCTURE 
Levobupivacaine [(S)-1-butyl-N-(2,6-dimethylphenyl) piperidine-2-carboxamide] is 
an amino-amide local anaesthetic drug belonging to the family of n-alkyl substitute 
pipecoloxylidide. Its chemical formula is C18 H28 N2 O. 
 
FIGURE 10: CHEMICAL STRUCTURE OF LEVOBUPIVACAINE 
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PHYSIOCHEMICAL PROPERTIES 
Levobupivacaine is a white crystalline powder freely soluble in water and 
alcohol, slightly soluble in chloroform and acetone. It is commercially available as 
Chirocaine. 
MECHANISM OF ACTION 
Levobupivacaine exerts its pharmacological action through reversible 
blockade of neuronal sodium channels. Myelinated nerves are blocked through 
exposure at the nodes of Ranvier more readily than unmyelinated nerves; and smaller 
nerves are blocked more easily than larger ones. In general, the progression of 
anaesthesia is related to the diameter, myelination and conduction velocity of the 
affected nerve fibres. Specifically, the drug binds to the intracellular portion(cell 
membrane) of voltage sensitive sodium channels and blocks sodium influx into nerve 
cells, which prevents depolarization. It also interferes with impulse transmission and 
conduction in other tissues.  
PHARMACOKINETICS 
1. ABSORPTION 
The dose as well as the route of administration of levobupivacaine determines 
the plasma concentration following therapeutic administration as the absorption is 
dependent upon the vascularity of the tissue. After epidural administration of 
levobupivacaine, the absorption is biphasic, with rapid absorption of a small quantity 
of drug into the circulation and slower absorption of the remainder of the drug. It has 
been observed that peak levels of levobupivacaine in the blood reaches approximately 
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30 min after epidural administration and doses up to 150 mg had resulted in mean 
Cmax levels up to 1.2 g/mL. The epidural absorption gets affected by age as the 
fraction absorbed decreases and the fast absorption phase is shorter in older (aged < 
70 years) compared with the younger (aged 18-44 years) patients. The older patients 
also have a higher spread of analgesia by ~ 3 dermatomes. Therefore, in the elderly 
patients a lower dose of levobupivacaine, according to their physical status is 
recommended.  
2. DISTRIBUTION: The volume of distribution is estimated at 66.91 ± 18.23 L 
(after intravenous administration of 40 mg in healthy volunteers). The pKa of 
levobupivacaine is 8.1, similar to the pKa of the racemic bupivacaine. The half-life is 
3.3h. The rate of clearance is 39.06 ± 13.29 L/h (after intravenous administration of 
40 mg in healthy volunteers).  
Alpha1-glycoprotein is the main binding site for levobupivacaine. Protein 
binding of levobupivacaine is more (97%) than that of racemic bupivacaine (95%). 
Less than 3% of the drug circulates free in plasma. The free proportion of the drug 
can have an action on the other tissues, causing unwanted side-effects and toxic 
manifestations. In newborns and in protein-deficient states like under nutrition and 
nephrotic syndrome, lesser amount of protein is available for binding, causing higher 
levels of free drug, resulting in toxic effects at lower doses.  
3. METABOLISM: Levobupivacaine is extensively metabolized with no unchanged 
levobupivacaine detected in urine or faeces. In vitro studies using (14 C) 
levobupivacaine showed that cytochrome  CYP3A4 isoform and CYP1A2 isoform 
mediate the metabolism of levobupivacaine to inactive metabolites, desbutyl 
41 
 
levobupivacaine and 3-hydroxy levobupivacaine, respectively. In vivo, the 3-hydroxy 
levobupivacaine appears to undergo further transformation to glucuronide and 
sulphate conjugates, which are excreted in urine. Metabolic inversion of 
levobupivacaine to R (+)-bupivacaine was not evident both in vitro and in vivo. 
4. EXCRETION: Following intravenous administration, recovery of the radio-
labelled dose of levobupivacaine was essentially quantitative with a mean total of 
about 95% being recovered in urine and faeces in 48 h. Of this 95%, about 71% was 
in urine while 24% was in faeces. 
Clinical Utility  
Levobupivacaine has been increasingly used in clinical anaesthesia practice 
since last few years because of its safer pharmacological profile. Literary evidence 
has established the safety of levobupivacaine over bupivacaine when used in regional 
anaesthesia as the incidence of various adverse outcomes is higher with the latter as 
compared to levobupivacaine.The low cardiovascular and neurological toxicity of 
levobupivacaine has led to its use as a local anaesthetic in a wide variety of specialist 
applications including sub-arachnoid block, epidural anaesthesia and analgesia, 
brachial plexus blocks, peripheral nerve blocks, ocular blocks as well as local 
infiltration. It is also being used for intraoperative anaesthesia, labour analgesia, post-
operative pain as well as for the management of acute and chronic pain. The 
introduction of levobupivacaine into Indian market recently has spurred the interest 
among anaesthesiologists to possibly use it in various clinical situations requiring 
regional anaesthesia. 
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Subarachnoid block 
Levobupivacaine is an interesting alternative to bupivacaine for spinal 
anaesthesia. Levobupivacaine produces subarachnoid block with similar sensory and 
motor characteristics and recovery like bupivacaine. The onset of sensory and motor 
block is hastened with the use of hyperbaric levobupivacaine as compared to isobaric 
levobupivacaine. The regression of motor block occurs earlier with levobupivacaine 
and ropivacaine as compared with bupivacaine. Intrathecal administration of 15 mg of 
levobupivacaine provides an adequate sensory and motor block lasting for 
approximately 6.5 h. Smaller doses (i.e., 5-10 mg) are used in day-care surgeries. At 
low concentrations, levobupivacaine produces a differential neuraxial block with 
preservation of motor function, which may be favourable for ambulatory surgery. 
Minimum effective local anaesthetic dose of levobupivacaine as recommended by an 
up- and-down sequential design study is 11.7 mg.The literary evidence has 
established that addition of opioids improves the quality of the block with less 
hemodynamic variations during peri-operative period. 
Epidural anaesthesia 
Levobupivacaine has been successfully used in providing epidural anaesthesia 
and analgesia for surgical procedures, which is clearly evident from the summary of 
various research works.Equal doses of levobupivacaine and bupivacaine (15 mL of 
0.5%) provide similar onset of sensory block (8-30 min), maximum cephalic spread 
(T7-T8) and duration of analgesia (4-6 h). Though, the onset of motor block is 
delayed with levobupivacaine it is less dense as compared to bupivacaine but with a 
similar duration.Higher concentration of levobupivacaine (i.e., 0.75% vs. 0.5%) 
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provides a longer duration of sensory and motor block without any increase in the 
incidence of adverse side effects. An increase in both volume and concentration of 
levobupivacaine is however associated with a higher incidence of hypotension (82%) 
and delayed block regression. The incidence of hypotension is similar when either 
levobupivacaine or bupivacaine is used for epidural anaesthesia for caesarean section. 
Levobupivacaine and bupivacaine when used in thoracic epidural anaesthesia provide 
comparable sensory block and intraoperative hemodynamics as well as similar 
duration of post-operative analgesia after thoracic surgery. 
Post-operative analgesia 
Epidural analgesia  
A continuous epidural infusion of low concentration of local anaesthetics with 
or without adjuvants provides excellent post-operative analgesia. Equipotent doses of 
levobupivacaine, bupivacaine and ropivacaine provide comparable post-operative 
pain relief and recovery of sensory and motor function. A continuous infusion of 15 
mg/h of levobupivacaine provides effective pain relief in the post-operative period. 
The quality of analgesia is also determined by the concentration of levobupivacaine, 
i.e., 0.25% solution provides better analgesia as compared to 0.125% or 0.0625% 
solutions. Levobupivacaine, self-administered via post-operative patient-controlled 
epidural analgesia also provides good post-operative pain control, similar to 
ropivacaine, but ambulation occurs earlier in ropivacaine-receiving patients. 
The addition of adjunctive agents (epinephrine, opioids or clonidine) to 
levobupivacaine in epidural anaesthesia and analgesia may provide a dose-sparing 
effect and increase the duration and quality of analgesia. Epinephrine does not 
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influence the onset, spread and duration of sensory and motor epidural block or the 
systemic absorption of levobupivacaine. Clonidine added to levobupivacaine also 
enhances the quality of analgesia and provides a local anaesthetic sparing effect. The 
motor block tends to be denser with clonidine and some degree of arterial hypotension 
occurs. 
Wound infiltration 
Local anaesthetic infiltration along the incision line is used frequently to 
provide postoperative analgesia. Post-incisional wound infiltration with 0.125% 
levobupivacaine provides more effective and longer duration of analgesia and early 
mobilization as compared to rectal paracetamol, in children after unilateral inguinal 
hernia surgery. Wound infiltration with levobupivacaine with or without tramadol 
provides good post-operative analgesia following a caesarean section or lumbar disc 
surgery. It also increased the inflammatory response and collagen synthesis on both 
the 8th and 21st days. 
Peripheral Nerve Blocks 
Different studies have compared levobupivacaine, ropivacaine and 
bupivacaine in brachial plexus block for upper limb surgeries. Levobupivacaine is a 
good substitute for bupivacaine. Compared to ropivacaine,  levobupivacaine provides 
a significantly longer duration of analgesia. The return of motor activity is earlier with 
ropivacaine. The long duration of sensory block associated with good analgesia and 
less toxicity of  levobupivacaine makes it a better choice for upper extremity blocks. 
Levobupivacaine 0.5% provides a longer duration of sensory block after sciatic nerve 
block using the Labat approach than the same dose of ropivacaine in foot and ankle 
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surgery. The use of a single dose of 0.5% levobupivacaine to block the tibial and 
peroneal nerves for hallux valgus surgery using popliteal approach is preferable over 
0.5% ropivacaine for good anaesthesia and better control of post-operative pain. 
Levobupivacaine 0.5% is as effective as bupivacaine 0.5% and is recommended for 
the 3-in-1 block. 
The quality and duration of peripheral nerve block is improved with the use of 
higher concentrations of levobupivacaine, (0.5-0.75%).Levobupivacaine administered 
via a peripheral nerve block continuous catheter provides excellent post-operative 
analgesia and decreases the post-operative systemic opioid requirements. The addition 
of adjuvants to the local anesthetics in peripheral nerve blocks such as epinephrine, 
clonidine or opioids improve the quality of analgesia and provide a dose-sparing 
effect, thereby decreasing the potential for systemic toxicity. Epinephrine does not 
add to the inherent long duration of sensory and motor block with levobupivacaine in 
peripheral nerve blocks but may help to decrease the potential for systemic toxicity. 
The addition of clonidine and fentanyl to levobupivacaine in paravertebral nerve 
block provides excellent analgesia and decreases post-operative systemic opioid  
requirement. Similarly, the addition of tramadol to levobupivacaine in middle 
interscalene block significantly increases the duration of sensory block. 
Obstetric Anaesthesia and Analgesia 
Subarachnoid block for caesarean delivery 
The time to onset of sensory and motor block as well as the duration of 
analgesia is slightly longer with intrathecal levobupivacaine as compared to 
bupivacaine in caesarean section. A potency hierarchy of intrathecal bupivacaine < 
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levobupivacaine < ropivacaine in caesarean section patients has been confirmed in 
clinical studies. The accidental intrathecal placement of an epidural-intended catheter 
can be confirmed with a test dose of 10 mg levobupivacaine.  
Labour analgesia 
Combined spinal-epidural labour analgesia  
Combined spinal-epidural (CSE) technique is widely used in obstetric practice 
to provide optimal analgesia. It offers effective, rapid-onset analgesia with minimal 
risk of toxicity. Minimum effective local anaesthetic concentration studies using a 
CSE analgesia technique (CSE) for labour confirm the potency hierarchy in the 
following order bupivacaine < levobupivacaine < ropivacaine. The intrathecal 
minimum local analgesic doses were 2.73-3.16 mg for levobupivacaine and 3.33-3.96 
mg for ropivacaine. The addition of fentanyl to levobupivacaine prolongs the duration 
and increases the success rate of the sensory block after intrathecal administration in a 
CSE analgesia technique.The addition of epinephrine to a mixture of levobupivacaine 
and opioid increases the success rate of sensory block, but also increases the 
frequency of motor blockade.  
Ophthalmic Surgery 
The low cardiovascular and neurological toxicity of levobupivacaine has led to 
its application as a preferred local anaesthetic in various ocular blocks including 
peribulbar block for cataract surgery and retro bulbar block for vitreo-retinal surgery. 
At equipotent doses and concentrations, 0.75% levobupivacaine provides more 
effective peribulbar anaesthesia and more effective post-operative analgesia for 
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vitreo-retinal surgery compared with 0.75% ropivacaine. Topical anaesthesia with 
levobupivacaine 0.75% has been found to be more effective than lidocaine 2% in 
preventing pain and improving patient and surgeon comfort during cataract surgery, 
with similar toxicity. Levobupivacaine (0.5%) has better anaesthetic properties with 
respect to 0.75% ropivacaine and is well-suited for peribulbar block in cataract 
surgery.  
Paediatric Anaesthesia 
Levobupivacaine is also increasingly being used in pediatric anaesthesia for 
subarachnoid block, caudal block, epidural anaesthesia and as a continuous epidural 
infusion for post-operative analgesia. 
Subarachnoid block 
The dose of levobupivacaine for spinal anaesthesia in neonates is slightly 
higher than for bupivacaine or ropivacaine. Appropriate doses for infant spinal 
anaesthesia are 1 mg/kg of isobaric 0.5% bupivacaine and ropivacaine and 1.2 mg/kg 
of isobaric 0.5% levobupivacaine.  
Caudal block 
The recommended dose of levobupivacaine for effective caudal anaesthesia 
has been reported to be 2.5 mg/kg. It appears to be of equivalent potency to racemic 
bupivacaine in children requiring lower abdominal surgery. Post-operative epidural 
infusions of 0.125% levobupivacaine or ropivacaine in children produce significantly 
less motor blockade with equally good analgesia as compared to a similar infusion of 
bupivacaine.  
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Geriatric Anaesthesia 
Elderly patients coming up for various surgeries including transurethral 
resection of the prostate or bladder tumour, orthopaedic trauma or joint replacement, 
cataract surgery, usually have some coexisting cardiac or pulmonary disease. Owing 
to its safer pharmacological profile, levobupivacaine is considered to be a better local 
anaesthetic than bupivacaine when used for subarachnoid block in the geriatric 
population having co-morbid systemic diseases.  
ADVERSE DRUG REACTIONS 
1. Hypotension 
2. Nausea, vomiting 
3. Dizziness, headache  
4. Tachycardia or bradycardia 
5. Effects due to over dosage or unintentional intravascular injection 
6. Neurological damage-rare complication. 
DRUG INTERACTIONS 
Metabolism of levobupivacaine may be prolonged by CYP3A4 inhibitors 
ketoconazole and CYP1A2 inhibitors methylxanthines. 
To be used with caution in patients receiving anti arrhythmic agents with local 
anaesthetic activity such as mexilitene. 
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PHARMACOLOGY OF DEXMEDETOMIDINE :( 28-31) 
 
FIGURE 11: CHEMICAL STRUCTURE OF DEXMEDETOMIDINE 
Dexmedetomidine is a potent and highly selective alpha 2 adrenoreceptor 
agonist. It exerts analgesic, sedative and anxiolytic effects after intravenous 
administration. It was introduced as a sedative especially useful when spontaneous 
breathing is essential. It is a valuable adjunct during surgery because of its anaesthetic 
and analgesic sparing effects. It has emerged as an alternative to propofol, opioids and 
benzodiazepines. 
MECHANISM OF ACTION :(29, 30) 
Highly selective for alpha 2 receptors over alpha 1(1620:1).Alpha 1 receptors 
are mainly involved with the regulation of vascular tone. Alpha 2 receptors are mainly 
pre and post synaptic receptors found in peripheral nervous system and central 
nervous system.Alpha 2A receptors are mainly located in locus ceruleus  and are 
responsible for sedation,anxiolysis and sympatholysis mediated by G protein 
inhibition of L type calcium channels. The effects of dexmedetomidine are subcortical 
and do not cause impairment of cognitive function. 
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Dexmedetomidine produces analgesic effect by action on alpha 2 receptors in 
locus ceruleus and spinal cord. Stimulation of alpha 2 receptors reduces central 
sympathetic output, results in increased firing of inhibitory neurons and alpha 2 
receptors in the dorsal horn of spinal cord modulates release of substance p to produce 
analgesic effects. 
EFFECTS ON CVS 
1. Decreased heart rate 
2. Decreased systemic vascular resistance 
3. Decreased myocardial contractility 
4. Decreased cardiac output 
5. Decreased systemic blood pressure. 
Beneficial effect on myocardial oxygen balance decreases perioperative myocardial 
ischemia in cardiac as well as non cardiac surgery. 
PHARMACOKINETICS :(30, 31) 
1. ABSORPTION & DISTRIBUTION 
Distribution half life after IV administration is 6 minutes. Volume of 
distribution is 118 l/kg and protein binding is 94%.Kinetics is linear over the dose 
range of 0.2 to 0.7 mcg/kg/hr.Dexmedetomidine exhibits linear pharmacokinetics in 
the dosage range of 0.2 to 0.7 mcg/kg/hr when administered by intravenous infusion 
for upto 24 hours. 
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2. METABOLISM 
Undergoes complete biotransformation in liver via glucuronidase and 
cytochrome p450 (CYP2A6)-mediated metabolism.The major metabolic pathways of 
dexmedetomidine are:direct N-glucuronidation to inactive metabolites; aliphatic 
hydroxylation(CYP2A6) to generate 3-hydroxy dexmedetomidine,glucuronide of 3 
hydroxydexmedetomidine and 3 carboxy dexmedetomidine; N-methylation of 
dexmedetomidine to generate 3 hydroxy N-methyl-dexmedetomidine,3 carboxy N-
methyl dexmedetomidine,and dexmedetomidine N-methyl O-glucuronide. 
3. EXCRETION 
Metabolites are eliminated via kidneys in urine (95%) and in faeces (4%) 
Elimination half life is 2 hours. Clearance rate 39 l/hr.  
DOSAGE: 1 Microgram/kg followed by 0.2 to 0.7 microgram/kg/hr. 
CLINICAL APPLICATIONS 
1. Attenuates hemodynamic response to laryngoscopy and intubation and reduces the 
dose requirement of other anaesthetic drugs. 
2. Improves perioperative hemodynamic stability in laparoscopic surgeries, 
craniotomies. 
3. Reduces myocardial oxygen demand and hence perioperative myocardial ischemia. 
4. IV/intrathecal/epidural dexmedetomidine prolongs the action of local anaesthetics. 
(Sensory, motor blockade and analgesia) 
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5. Used for induced hypotension in ENT surgeries 
6. For ICU and short procedural sedation. 
DRUG INTERACTIONS 
Administration with other sedatives results in enhanced sedative effects. Although 
dexmedetomidine undergoes metabolism by CYP450, no drug interactions involving 
this pathway have been identified. 
Concurrent administration of dexmedetomidine and digoxin results in severe 
bradycardia. 
ADVERSE REACTIONS 
1. Hypotension, bradycardia, sedation 
2. Nausea, vomiting 
3. Dry mouth 
4. Cardiac arrest 
5. Urinary retention 
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REVIEW OF LITERATURE 
Jung SM et al(32) conducted a randomized double blind study to compare the 
efficacy and safety of epidural anaesthesia produced by levobupivacaine,bupivacaine and 
ropivacaine for cesarean section.90 parturients undergoing elective caesarean received 
epidural block with 20 ml of 0.5% bupivcaine(group B),0.5% ropivacaine(group R) or 
0.5% levobupivacaine (group L).Onset time to T6 was 15.7+/-9.8 mins in group 
L,11.1+/-5.9 mins in group B,18.1+/-13.1 mins in group R.Maximal block height 
achieved was T4 in all three groups.They also concluded that levobupivacaine produced 
longer duration of  sensory block and shorter duration of motor blockade than 
bupivacaine and ropivacaine.Bupivacaine produced longer duration and higher incidence 
of Bromage 3 motor block.Degrees of abdominal muscle relaxation were comparable in 
all groups. 
Peduto VA et al(33) compared the onset time and duration of epidural anaesthesia 
produced by levobupivacaine and ropivacaine.ASA PS I-III adults undergoing elective 
lower limb procedures were randomized to receive epidural levobupivacaine 0.5% 15 ml 
or epidural ropivacaine 0.75% 15 ml.With levobupivacaine onset time was 29+/-24 min 
and with ropivacaine it was 25+/-22 min.Complete resolution of motor block was 
105+/63 min with levobupivacaine and 95+/-48 min ropivacaine. 
Bader AM et al(34) compared the efficacy of 0.5% levobupivacaine with 0.5% 
bupivacaine for epidural anaesthesia in 60 parturients undergoing elective caesarean 
delivery.patients randomly received 30 ml of either 0.5%levobupivacaine or 0.5% 
bupivacaine.Levels of sensory block,motor block,muscle relaxation and overall quality of 
anaesthesia did not differ between groups.The incidence of hypotension was 84.4% in the 
levobupivacaine group and 100% in the bupivacaine group. 
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Cox CR et al(35) compared the clinical efficacy and safety of levobupivacaine with 
bupivacaine for epidural anaesthesia.88 patients undergoing elective lower limb surgery 
under lumbar epidural anaesthesia received 15 ml of 0.5% levobupivacaine or 0.5% 
bupivacaine in a double blind manner.There was no difference in onset time,maximum 
spread of  sensory block or intensity of motor block between the two groups. 
A randomized double blind study conducted by Tanakka & Ogleari et al(36) 
included 87 patients undergoing lower abdominal procedures in epidural anaesthesia. 
Group 1 given 0.5% levobupivacaine, group 2 given 50% enantiomeric excess 0.5% 
bupivacaine and group 3 given 0.5% bupivacaine. It was concluded that 
levobupivacaine produced less motor block as compared to other compounds. 
In a study conducted by Cox et al 1998(35) ,onset of sensory block ranged between 
8 to 30 minutes with maximum upper spread T7-T8 after L2-L3 or L3-L4 lumbar 
epidural injection and duration 4-6 hours are similar after equal doses of levobupivacaine 
and bupivacaine(15 ml of 0.5%) 
A study conducted by Kopacz et al 2000(37) found that the onset of motor block is 
slower with levobupivacaine and the quality of motor blockade follows the rank of order 
bupivacaine>levobupivacaine>ropivacaine. However increasing both volume and 
concentration of levobupivacaine prolong the duration of  both sensory and motor 
blockade which is associated with high incidence of  hypotension(82%) and delayed 
block regression. 
As reported by Casati et al (38) a better way to control the quality and duration of 
epidural block with levobupivacaine without any hemodynamic consequences is via 
continuous epidural infusion. It was also shown that a continuous epidural infusion is 
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associated with excellent postoperative analgesia and similar recovery of sensory and 
motor function after equipotent doses of   levobupivacaine, bupivacaine and ropivacaine. 
A study conducted by Murdoch et al(2002)(39)compared the continuous epidural 
infusion of 0.0625% levobupivacaine with 0.125% levobupivacaine at 6 ml/hr for hip & 
knee replacement surgeries and found that the effective dose of epidural levobupivacaine 
for continuous postoperative analgesia approached to 15 mg/hr. 
Dernedde et al 2006(40) in their study found that the use of large concentration, 
small volume of epidural infusion (i.e) 3ml/hr of  levobupivacaine 0.5% provides better 
analgesia with significant hemodynamic stability 
Wang LZ and Chang XY et al(41) compared bupivacaine,ropivacaine and 
levobupivacaine with sufentanil for patient controlled epidural analgesia during 
labour and concluded that equipotent low concentrations of levobupivacaine, 
bupivacaine and ropivacaine, all with the addition of sufentanil 10 mcg, produce 
similar pain relief and motor block, but levobupivacaine and ropivacaine produce a 
longer lasting analgesia. In patient-controlled epidural analgesia, concentrations of 
<0.1% levobupivacaine, bupivacaine and ropivacaine with sufentanil produce similar 
analgesia and motor block with safety for labour analgesia. Both levobupivacaine and 
ropivacaine are being favored in labour analgesia because of less motor block and less 
toxicity as compared to bupivacaine.They also found that the analgesic efficacy 
mainly depends on the concentration rather than the type of anaesthetics and at least 
0.1% is needed for satisfactory analgesia. They concluded that Levobupivacaine, 
Ropivacaine and Bupivacaine all confer adequate and safe labour analgesia, with no 
significant influence on the mode of delivery, duration of labour, or neonatal 
outcome.  
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 Elhakim M, Abdelhamid D, Abdelfattach H, Magdy H.et.al (2010)(42) 
conducted study on 50 adult male patients in thoracic surgery with open lung 
ventilation, where after induction of general anaesthesia group D received epidural 
dexmedetomidine 1 mcg/kg with bupivacaine 0.5% & group B received epidural 
bupivacaine 0.5% alone. They found that use of epidural dexmedetomidine decreases 
the anaesthetic requirements significantly, prevents awareness during anaesthesia and 
improves intraoperative oxygenation and post-operative analgesia. (44) 
Lopez et al(43) conducted a study on 40 patients for surgery on abdomen and 
lower limbs (ASAI and II) in a single group. They were given epidural 
dexmedetomidine 1µ/kg plus lidocaine and epinephrine .It was concluded that use of 
dexmedetomidine reduces the doses of local anaesthetics as it potentiates the effect of 
both drugs, with consequent reduction of their adverse effects.  
Kanazi et al(44) compared in their study the effects of supplementation of 
epidural 0.5%bupivacaine with 50 micrograms dexmedetomidine epidurally on 60 
patients of ASA I & II. They concluded that epidural bupivacaine with 
dexmedetomidine produced significantly longer sensory and motor blocks with 
shorter onset of motor block  in comparison to epidural bupivacaine alone. 
           Kamal et al(45) conducted a comparative study on epidural dexmedetomidine vs 
epidural morphine added to epidural 0.5% levobupivacaine and found that both the 
additives produced comparable sensory and motor blockade. There was no statistical 
significance between the two groups as regards the onset of sensory block, time to 
total regression of motor or sensory block or maximum sensory block level.Time to 
reach total motor block was significantly shorter in the Morphine group(LM) than the 
Dexmedetomidine group(LD).There was no statistically significant difference 
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between the two groups in the degree of muscle relaxation.There was no statistically 
significant difference as regards nausea vomiting or respiratory depression. However, 
5 patients (16.6%) in the LM group suffered from pruritis while no patient suffered 
from it in the LD group, and 6 patients (20%) suffered from dry mouth in the LD 
group while no patient suffered from it in the LM group. 
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METHODOLOGY 
 PATIENT SELECTION 
GROUP A:     30 patients who received 20 ml of epidural 0.5% isobaric 
Levobupivacaine with 0.5 ml distilled water. 
GROUP B:     30 patients who received 20 ml of epidural 0.5% isobaric 
Levobupivacaine with 0.5 ml of Dexmedetomidine containing 50µg. 
 INCLUSION CRITERIA 
 Adult patients of either sex belonging to the age group 25-45 years weighing  
between 50-70kg with BMI ranging between 19-24. 
 Patients undergoing  elective infraumbilical and lower limb surgeries with site  
of incision below T10 level such as: 
 Inguinal hernia-Hernioplasty/Herniorrhaphy 
 Appendicitis-Open appendicectomy 
 Hydrocele sac eversion 
 Incisional hernia-Anatomical repair/mesh  repair 
 Varicose veins-Trendelenberg procedure 
 Varicocele 
 Split skin grafting & flap cover. 
 ASA I & ASA II 
 Consent from patient 
 Duration of surgery not more than 2 hours. 
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 EXCLUSION CRITERIA 
 Patients not willing for the study 
 Pregnant women 
 ASA III & ASA IV 
 Patients  who are known to be allergic to study drugs 
 Patients in sepsis  
 Emergency surgeries 
 Infection at the site of injection 
 Coagulopathy or other bleeding diathesis 
 Severe hypovolemia 
 Orthopaedic surgeries 
 Gynaecological surgeries 
 Duration of surgery  more than 2 hours 
DRUGS USED 
 Inj 0.5% Isobaric Levobupivacaine       
 Inj Dexmedetomidine  
 Inj Ephedrine  
 Inj Atropine  
 Inj Midazolam  
MONITORS USED 
 Pulse oximeter, NIBP, ECG,Temperature monitors. 
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MATERIALS & METHODS 
 A randomized controlled double blind study was planned. The study solutions 
were prepared by an anaesthesiologist not involved in the patient care. Patient 
and anaesthesiologist who delivered the epidural anaesthesia were blinded to 
the study solutions. 
 In case of any emergencies arising, it was planned to decode the patients 
immediately and patients would be treated accordingly. 
 Sampling was based on statistical record of surgical cases done at KMCH & 
GRH. According to the operative statistics of the year 2013, around 1200 
surgical cases(lower abdominal & lower limb surgeries) have been performed 
(inclusive of both hospitals) over a period of 6 months. 
 So based on the above data, out of 600 cases, 60 patients who fulfilled the 
inclusion criteria were chosen for the study over a period of 6 months. 
 All pre-anaesthetic evaluation of the 60 patients under the inclusion criteria 
were performed a day before the surgery. All 60 patients, after being taken a 
written informed valid consent were randomly allocated into the following 
groups. 
Group A (n=30) =patients who received epidural 0.5% isobaric 
Levobupivacaine 20 ml with 0.5 ml of distilled water. 
Group B (n=30) =patients who received epidural 0.5% isobaric 
Levobupivacaine 20 ml   plus  0.5 ml Dexmedetomidine containing 50µg.  
  In the operation theatre good peripheral intravenous access was secured using 
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18 gauge cannula. 
 Baseline non invasive blood pressure, ECG, pulse rate and SpO2 were 
recorded. 
 All patients received Ringer lactate solution 20ml/kg as preloading solution 
before the block. Intravenous fluids were given as per body weight and 
operative loss requirement. 
 Patients were positioned on their right lateral side and skin over the desired 
site was infiltrated with 1% lignocaine 2ml. 
   L2-L3/L3-L4 interspaces were selected and epidural space identified using 
18G Tuohy needles, midline approach, using loss of resistance technique with 
air. 
  After exclusion of blood in the needle with negative aspiration, 2 ml of 0.5% 
isobaric levobupivacaine was injected to exclude intrathecal placement of the 
needle. 
 After which the epidural catheter was inserted and fixed 5 cm inside. Now 
patients in group A  received 18 ml of 0.5% isobaric Levobupivacaine with 
0.5 ml distilled water and group B received 18 ml of 0.5% isobaric 
Levobupivacaine  plus 0.5 ml of  Dexmedetomidine containing 50µg 
epidurally. 
PARAMETERS OBSERVED WERE 
 Baseline pulse rate, SpO2 at room air, noninvasive blood pressure were  
recorded. 
 Cardio respiratory parameters were monitored continuously and recordings 
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were made every 5 minutes until 30 minutes and at 10 minute interval for the 
first 2 hours and for every hour till 6 hours, thereafter 2 hourly till 12 hours 
 Intraoperatively, incidence of bradycardia (heart rate<50beats per minute) was 
treated with 0.6mg of Injection Atropine i.v and hypotension (systolic blood 
pressure falling more than 20% from the baseline value) was treated with 
Injection Ephedrine 6 mg IV. 
 Time to sensory block at T10 dermatome is the time interval between the 
initiation of anaesthesia and the onset of cutaneous analgesia at T10.This was 
evaluated using midline bilateral pin prick every minute till complete loss of 
cutaneous sensation at T10 at which point surgery was proceeded. 
 Maximum level of sensory block reached and time taken to achieve the same. 
 Time of onset of motor block (defined as onset of motor block to Bromage 
scale 1) and degree of motor blockade was assessed using modified Bromage 
scale. 
0= No block  
1=Inability to raise extended leg 
2=inability to flex the knee 
3=inability to flex ankle and foot        
 Sedation scores were recorded just before the initiation of surgery and every 
30 minutes. Level of sedation was assessed using Ramsay 5 point scale. 
1=alert and wide awake 
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2=arousable to verbal commands 
3=arousable to gentle tactile stimulation 
4=arousable to vigorous shaking 
5=unarousable 
 Duration of analgesia was recorded as time interval from the completion of 
administration of anaesthetic agent to the time when the patient complains of  pain 
at the surgical incision site with VAS score >3. Procedure was explained and the 
patients were taught to assess the onset of pain using the visual analogue scale 
(VAS). In the visual analogue scale the patients were shown a scale of 10 cm 
length. Zero end of the scale was taken as 'No pain' and 10 cm mark as 'Maximum 
pain'. Intensity of pain increases gradually from '0' to '10'. VAS score was assessed 
hourly from the time of completion of surgery. Patients were instructed to point the 
onset of pain on the scale when VAS score>3.  
 Duration of sensory blockade was noted as time interval from the epidural 
administration of anaesthetic agent till the regression of sensory level to S1. 
 Duration of motor blockade was noted as the time interval from the epidural 
administration of anaesthetic agent till regression of motor blockade to modified 
Bromage scale 0. 
 During surgical procedure adverse effects like nausea, vomiting, dry mouth, 
dizziness, headache, respiratory depression, pruritis and shivering were recorded. 
 Any postoperative untoward side effects were noted for 48 hours. 
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 STATISTICAL ANALYSIS 
Descriptive statistical analysis has been carried out in the present study. Results on 
continuous measurements are presented as Mean  SD and results on categorical 
measurements are presented as percentage (%). Chi-square test has been used to find 
the significance of study parameters on categorical scale between two groups. 
Student‘t’ test has been used to determine the significance between the means of two 
groups. All analyses were two tailed and p <0.05 was considered significant. SPSS 
version 16.0 was used for data analysis.    
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OBSERVATION AND RESULTS 
Sixty patients of either sex belonging to ASA I and II were selected and 
randomly divided into two groups. The data collected were analysed and the results 
were tabulated using the Statistical Package for Social Sciences. Appropriate 
statistical analysis of data were done using following tests: 
1. Student t test for parametric data. 
2. Chi-square test for non parametric data. 
 P<0.05 was  considered as statistically significant. 
AGE DISTRIBUTION 
There  was  no  statistically  significant  difference  in  the distribution of  age  
among the two groups, the p value being 0.693.  
AGE (IN YEARS)  
GROUP MEAN STANDARD 
DEVIATION 
p-VALUE 
A 35.17 4.969 0.693 
B 34.63 5.147 
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SEX DISTRIBUTION 
The distribution of sex between the two groups did not have statistical 
difference with p value of 1. 
P value-1.000 
 
 GROUP  
SEX 
Male Female 
 
A Count  %  within Group 
22 
73.3% 
8 
26.7% 
 B Count % within Group 
22 
73.3% 
8 
26.7% 
Total  Count % within  Group 
44 
73.3% 
16 
26.7% 
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HEIGHT DISTRIBUTION 
The difference in height distribution among the two groups was not 
statistically significant, P value being 0.166. 
HEIGHT (IN CENTIMETRES)  
GROUP MEAN STANDARD 
DEVIATION 
p-VALUE 
A 163.93 4.193 0.166 
B 165.40 3.900 
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WEIGHT DISTRIBUTION 
The difference in weight distribution among the two groups was not 
statistically significant, P value being 0.667. 
WEIGHT (IN KG)  
GROUP MEAN STANDARD 
DEVIATION 
p-VALUE 
A 61.77 5.250 0.667 
B 61.20 4.895 
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ASA STATUS 
The ASA status was not statistically significant among the two groups. 
 PS I PS  II 
GROUP Number % Number % 
A 25 83.3 5 16.7 
B 25 83.3 5 16.7 
P=1.000 
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DURATION OF SURGERY 
There was no statistically significant difference between the two 
groups in the duration of surgery with P value being 0.856. 
DURATION OF SURGERY (IN MINUTES) 
GROUP MEAN STANDARD 
DEVIATION 
p-VALUE 
A 85.67 15.241 0.856 
B 86.50 19.963 
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TIME OF ONSET OF SENSORY BLOCK TO T10 
The time of onset of sensory block to T10 level was slightly lesser with group 
B (11.4 minutes) than group A (12.5 minutes) but was not statistically significant 
between the two groups with p value being 0.224. 
TIME OF ONSET OF SENSORY BLOCK TO T10 LEVEL (IN MINUTES) 
GROUP MEAN STANDARD 
DEVIATION 
p-VALUE 
A 12.47 3.560 0.224 
B 11.40 3.158 
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MAXIMUM SENSORY HEIGHT 
The maximum sensory height attained was T4-T6 for group B and T6-T8 for 
group A with much statistical difference between the 2 groups (p value-0.00004) 
DISTRIBUTION OF SENSORY BLOCK BY GROUP 
 T4 T6 T8 
GROUP NUMBER % NUMBER % NUMBER % 
A 2 6.7 22 73.3 6 20.0 
B 17 56.7 13 43.3 0 0.0 
p value=0.00004 
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TIME TAKEN TO ACHIEVE MAXIMUM SENSORY HEIGHT 
The time taken to achieve maximum sensory height was shorter with group B 
(18.1 minutes) when compared to group A (19.7minutes) but was statistically 
insignificant with p value of 0.126. 
 
 
TIMETAKEN TO ACHIEVE MAXIMUM SENSORY LEVEL(IN MINUTES) 
GROUP MEAN STANDARD DEVIATION p-VALUE 
A 19.67 3.604 
0.126 
B 18.07 4.346 
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TIME OF ONSET OF MOTOR BLOCKADE  
(BROMAGE SCALE 1) 
The time of onset of motor blockade is the time taken to achieve Bromage 
scale 1 which was statistically significant between the two groups with p value of 
0.000. 
 
ONSET TIME FOR MOTOR BLOCKADE (IN MINUTES) 
GROUP MEAN STANDARD DEVIATION p-VALUE 
A 19.33 4.498 
0.000 
B 14.50 3.560 
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MAXIMUM MOTOR BLOCKADE ACHIEVED 
Maximum motor blockade achieved showed statistical significance(p value 
0.0000  between the two groups with bromage scale of 2 to 3 achieved in group B and 
Bromage scale of 1 to 2 achieved in group A. 
DISTRIBUTION OF MOTOR BLOCK BY GROUP 
 T4 T6 T8 
GROUP NUMBER % NUMBER % NUMBER % 
A 14 46.67 10 33.3 6 20.0 
B   6 20.0 24 80.0 
p value 0.0000 
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TIME TAKEN TO ACHIEVE MAXIMAL MOTOR BLOCKADE 
Time taken to achieve maximum motor blockade was significantly shorter 
with group B (22.17 minutes) compared to group A (27.83 minutes) which is 
statistically significant (p value-0.006). 
 
 
 
TIME TAKEN TO ACHIEVE MAXIMAL MOTOR BLOCKADE (IN 
MINUTES) 
GROUP MEAN STANDARD DEVIATION p-VALUE 
A 27.83 5.522 
0.006 
B 22.17 4.488 
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DURATION OF SENSORY BLOCKADE 
The duration of sensory blockade was defined as time taken for regression of 
sensory blockade to S1 level which was prolonged in group B (568 minutes) when 
compared to group A (459.5 minutes) and was statistically significant, p value 0.000 
 
 
 
DURATION OF SENSORY BLOCKADE (IN MINUTES) 
GROUP MEAN STANDARD DEVIATION p-VALUE 
A 459.5 49.119 
0.000 
B 568 44.346 
78 
 
351.7
477.8
0.0
100.0
200.0
300.0
400.0
500.0
600.0
GroupA GroupB
m
i
n
u
t
e
s
Duration of analgesia by group
DURATION OF ANALGESIA 
Duration of analgesia is prolonged with group B (477.83 minutes) when 
compared to group A (351.67 minutes) which shows statistical significance with p 
value of 0.000. 
 
 
DURATION OF ANALGESIA (IN MINUTES) 
GROUP MEAN STANDARD DEVIATION p-VALUE 
A 351.67 54.730 
0.000 
B 477.83 44.580 
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DURATION OF MOTOR BLOCKADE 
The time duration of motor blockade is taken as the time for the motor 
blockade to return to Modified Bromage scale 0 and was statistically significant 
between two groups P value of 0.000. 
 
 
DURATION OF SENSORY BLOCKADE (IN MINUTES) 
GROUP MEAN STANDARD DEVIATION p-VALUE 
A 127.5 24.309 
0.000 
B 265.33 35.183 
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HEART RATE 
The heart rate recorded between 25 to 100 minutes was found to be 
statistically significant between the 2 groups. 
TIME 
INTERVAL 
(MINUTES) 
GROUP MEAN HEART RATE(BEATS/MINUTE) 
STANDARD 
DEVIATION 
p-
VALUE 
Basal A B 
83.73 
87.20 
6.384 
7.622 0.061 
1 A B 
86.60 
89.93 
6.871 
6.357 0.056 
5 A B 
83.10 
86.73 
7.355 
7.763 0.068 
10 A B 
81.40 
82.27 
6.371 
6.362 0.600 
15 A B 
79.13 
77.67 
6.678 
7.845 0.439 
20 A B 
78.87 
77.47 
6.522 
7.780 0.442 
25 A B 
76.20 
72.20 
5.616 
8.006 0.029 
30 A B 
74.87 
68.60 
5.625 
7.185 0.000 
40 A B 
73.53 
65.13 
6.616 
7.514 0.000 
50 A B 
72.93 
62.33 
6.074 
7.685 0.000 
60 A B 
71.47 
62.07 
5.823 
6.918 0.000 
70 A B 
72.00 
62.64 
4.751 
5.813 0.000 
80 A B 
71.50 
62.59 
4.628 
6.073 0.000 
90 A B 
71.41 
61.00 
3.519 
3.658 0.000 
100 A B 
70.25 
62.00 
5.175 
3.225 0.000 
110 A B 
68.50 
63.20 
4.726 
5.215 0.156 
120 A B 
70.00 
62.67 
2.000 
3.055 0.025 
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 SYSTOLIC BLOOD PRESSURE: 
The systolic blood pressures recorded at 15,20,25,30,40,50,60 
minutes were significant statistically. 
TIME 
INTERVAL 
(MINUTES) 
GROUP 
MEAN 
SYSTOLIC 
BLOOD 
PRESSURE 
(MM HG) 
STANDARD 
DEVIATION p-VALUE 
Basal A B 
122.60 
122.13 
9.427 
7.718 0.835 
1 A B 
122.07 
117.53 
8.952 
22.442 0.308 
5 A B 
119.80 
115.27 
9.223 
8.686 0.055 
10 A B 
115.80 
111.47 
7.034 
10.621 0.068 
15 A B 
113.83 
118.40 
7.297 
10.026 
0.020 
 
20 A B 
112.53 
105.27 
8.337 
10.272 0.004 
25 A B 
110.87 
102.67 
9.153 
11.009 0.003 
30 A B 
110.80 
102.87 
9.650 
11.334 0.005 
40 A B 
110.60 
100.53 
9.220 
11.826 0.001 
50 A B 
109.60 
100.93 
9.676 
11.026 0.002 
60 A B 
108.20 
102.27 
10.230 
9.288 0.022 
70 A B 
107.93 
104.00 
7.454 
10.066 0.099 
80 A B 
107.70 
105.00 
8.927 
11.402 0.419 
90 A B 
109.76 
112.36 
9.641 
35.763 0.776 
100 A B 
109.75 
107.82 
7.741 
9.527 0.644 
110 A B 
109.50 
106.00 
7.724 
10.392 0.594 
120 A B 
104.00 
102.00 
2.000 
2.000 0.288 
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DIASTOLIC BLOOD PRESSURE 
In this study the diastolic blood pressure recorded at 5, 10,15,20,25,30,40,50 
minutes were statistically significant. 
TIME 
INTERVAL 
(MINUTES) 
GROUP MEAN 
DIASTOLIC 
BLOOD 
PRESSURE 
(MM HG) 
STANDARD 
DEVIATION 
p-VALUE 
Basal A 
B 
74.87 
74.53 
6.027 
6.345 
0.835 
1 A 
B 
74.73 
73.20 
6.443 
7.327 
0.393 
5 A 
B 
71.73 
67.60 
5.747 
7.190 
0.017 
10 A 
B 
70.20 
63.93 
5.762 
7.511 
0.001 
15 A 
B 
67.53 
61.53 
5.698 
6.637 
0.000 
20 A 
B 
66.33 
60.87 
6.870 
7.855 
0.006 
25 A 
B 
66.27 
60.27 
6.963 
6.680 
0.001 
30 A 
B 
64.80 
60.67 
7.730 
7.919 
0.045 
40 A 
B 
64.07 
59.67 
7.153 
9.686 
0.050 
50 A 
B 
63.93 
59.20 
7.904 
7.959 
0.024 
60 A 
B 
63.53 
61.40 
8.148 
7.486 
0.295 
70 A 
B 
64.07 
62.07 
7.662 
6.049 
0.280 
80 A 
B 
65.50 
64.33 
7.619 
5.099 
0.587 
90 A 
B 
65.88 
64.71 
7.193 
6.866 
0.650 
100 A 
B 
67.50 
65.82 
6.655 
5.964 
0.571 
110 A 
B 
66.00 
67.20 
6.733 
9.654 
0.840 
120 A 
B 
64.00 
63.33 
4.000 
5.033 
0.866 
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MEAN ARTERIAL BLOOD PRESSURE 
Mean arterial blood pressure recorded at 5, 10, 15,20,25,30,40,50,60 minutes 
were found to be statistically significant. 
TIME 
INTERVAL 
(MINUTES) 
GROUP MEAN OF 
MEAN 
ARTERIAL 
BLOOD 
PRESSURE 
(MM HG) 
STANDARD 
DEVIATION 
p-VALUE 
Basal A 
B 
90.97 
90.60 
5.327 
5.143 
0.787 
1 A 
B 
90.73 
89.27 
5.105 
6.085 
0.316 
5 A 
B 
87.83 
83.47 
5.497 
6.816 
0.008 
10 A 
B 
85.33 
79.60 
4.751 
8.067 
0.002 
15 A 
B 
83.03 
77.10 
4.664 
6.989 
0.000 
20 A 
B 
81.73 
75.67 
5.977 
8.049 
0.002 
25 A 
B 
81.20 
74.40 
6.718 
7.403 
0.000 
30 A 
B 
79.50 
74.70 
7.385 
8.014 
0.019 
40 A 
B 
79.57 
73.27 
6.831 
9.791 
0.005 
50 A 
B 
79.17 
73.13 
7.525 
8.402 
0.005 
60 A 
B 
78.63 
74.30 
7.872 
7.603 
0.034 
 
70 A 
B 
78.76 
76.14 
6.162 
6.604 
0.128 
80 A 
B 
79.65 
77.47 
7.307 
7.985 
0.392 
90 A 
B 
80.47 
76.93 
7.383 
8.204 
0.216 
100 A 
B 
81.62 
78.55 
5.829 
8.745 
0.400 
110 A 
B 
80.50 
80.00 
6.856 
9.798 
0.934 
120 A 
B 
77.67 
76.33 
3.055 
4.041 
0.672 
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OXYGEN SATURATION: SpO2 
There was no significant difference between the two groups with regards to 
oxygen saturation. 
TIME 
INTERVAL 
(MINUTES) 
GROUP MEAN OF 
SpO2 (%) 
STANDARD 
DEVIATION 
p-VALUE 
Basal A 
B 
98.67 
98.60 
0.661 
0.563 
0.676 
1 A 
B 
98.70 
98.67 
0.651 
0.547 
0.831 
5 A 
B 
98.70 
98.53 
0.535 
0.507 
0.221 
10 A 
B 
98.63 
98.37 
0.556 
0.490 
0.054 
15 A 
B 
98.60 
98.57 
0.675 
0.504 
0.829 
20 A 
B 
98.60 
98.47 
0.563 
0.507 
0.339 
25 A 
B 
98.70 
98.47 
0.596 
0.507 
0.108 
30 A 
B 
98.70 
98.50 
0.651 
0.509 
0.190 
40 A 
B 
98.53 
98.53 
0.571 
0.507 
1.000 
50 A 
B 
98.43 
98.50 
0.504 
0.572 
0.634 
60 A 
B 
98.57 
98.50 
0.626 
0.509 
0.652 
 
70 A 
B 
98.53 
98.33 
0.507 
0.479 
0.122 
80 A 
B 
98.83 
98.53 
0.648 
0.571 
0.062 
90 A 
B 
98.50 
98.47 
0.572 
0.507 
0.812 
100 A 
B 
98.60 
98.40 
0.621 
0.498 
0.174 
110 A 
B 
98.50 
98.40 
0.572 
0.498 
0.473 
120 A 
B 
98.67 
98.43 
0.606 
0.504 
0.111 
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ADVERSE EFFECTS 
Adverse effects were reported in 16.7% of patients in group A and 30% of 
patients in group B.But hypotension/bradycardia (fall of >20% from the baseline) 
requiring treatment with Inj Ephedrine / Inj Atropine) were found to be statistically 
insignificant while comparing the two groups. 
DISTRIBUTION OF ADVERSE EFFECTS IN BOTH GROUPS 
ADVERSE EFFECTS  GROUP Group A Group B 
Dry Mouth Count  % within Group - 
1 
3.33% 
Nausea Vomiting Count % within Group 
1 
3.33% 
1 
3.33% 
Shivering Count %  within Group - 
2 
6.67% 
Urinary Retention Count % within Group 
2 
6.67% - 
Hypotension Count % within Group 
2 
6.67% 
3 
10% 
Bradycardia Count % within Group - 
2 
6.67% 
OVERALL DISTRIBUTION OF ADVERSE EFFECTS 
Group Yes % No % 
A 5 16.67 25 83.3 
B 9 30 21 70.0 
Total 14 23.33 46 75.40 
p-value-0.3598 
  
91 
 
83.3
16.7
70.0
30.0
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
NO yes
%
DISTRIBUTION OF ADVERSE EFFECTS BY GROUP
GroupA GroupB
             
 
ADVERSE EFFECTS REQUIRING TREATMENT IN BOTH 
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p VALUE-0.999  
GROUP NUMBER % 
A 2 6.67 
B 5 16.67 
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SEDATION SCORE: 
Mode sedation score in group B (Dexmedetomidine group) was found to be 2 
at all points of time as per Ramsay scoring. 
SEDATION SCORE AT  VARIOUS TIME INTERVALS 
TIME INTERVAL 
IN MINUTES 
MEAN MEDIAN MODE 
BASAL 1 1 1 
30 1.87 2 2 
60 2.27 2 2 
90 2.03 2 2 
120 1.63 2 2 
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DISCUSSION 
This study compared the effects of addition of  epidural dexmedetomidine(50 
micrograms) to epidural 0.5% levobupivacaine 20 ml for infraumbilical & lower limb 
surgeries. 
1.DEMOGRAPHIC DATA 
Demographic parameters such as age, sex, height  & weight have no statistically 
significant  difference between the two groups. Distribution of ASA status was also 
similar in both groups. 
2.TIME OF ONSET OF SENSORY BLOCKADE 
Onset time to sensory block at T 10 level was defined as time taken from the 
injection of local anaesthetic till the loss of sensation for pin prick at T10 level.In this 
study,mean time of onset of sensory blockade to T10  level was 12.47 minutes for group 
A & 11.4 minutes for group B which shows that the onset is slightly earlier with group B 
but was not found to be statistically significant.(p value 0.224) 
Kopacz et al(2001)(46)  in their study found the mean time of onset of sensory 
block to T10 level to be 13 minutes with epidural 0.5% levobupivacaine 20 ml and with 
the addition of dexmedetomidine the mean onset time was 11.5 minutes. 
3. MAXIMUM SENSORY LEVEL REACHED AND TIME TAKEN 
Maximium sensory height reached ranged from T6 to T8 in group A compared to T4 to 
T6 in group B with p value of 0.00004 which is statistically significant.This is in accordance with 
the studies conducted by Cox et al(35) in which the maximum sensory levels attained were T8 
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and T6 with epidural 0.5% levobupivacaine and with the addition of epidural 
dexmedetomidine respectively. Bajwa et al(47) also found the maximum sensory level to 
range between T4 to T6 with the addition of epidural dexmedetomidine. 
       With regard to the mean time taken to achieve the maximum sensory level,it was 
found to be 19.67 minutes in group A and 18.07 minutes in group B which was not found 
to be statistically significant(p value 0.126).This correlates with the study conducted by 
Saurav et al(48) who showed that the time taken to achieve the uppermost sensory level 
with 0.5% levobupivacaine was 13.5+/-7.5 minutes and 13.38+/-4.48 minutes with the 
addition of epidural dexmedetomidine 50 micrograms. 
4. TIME OF ONSET OF MOTOR BLOCKADE 
Onset time to motor blockade has been defined as time taken to achieve motor 
blockade of  Bromage scale 1from the time of  injection of local anaesthetic. This study 
found the mean time to onset of motor blockade to be 19.33 minutes in group A as 
opposed to 14.5 minutes in group B which was statistically significant  with p value of  
0.000. 
As already pointed out by Kopacz et al(46) and Murdoch et al(39) the onset time to 
motor blockade is slower  with 0.5%  levobupivacaine with mean onset time being  20+/-
5 minutes but is hastened with the addition of  dexmedetomidine(14.24+/5.52 minutes). 
Bajwa et al(47) also found that the onset time to motor blockade is significantly shorter 
with the addition of dexmedetomidine with mean time ranging between 15.14+/-4.52 
minutes.   
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5. DEGREE OF MOTOR BLOCKADE AND TIME TAKEN TO ACHIEVE 
The comparison of degree of motor blockade between the 2 groups showed 
statistical significance with group B patients having maximum degree of motor 
blockade (Bromage 3) than in group A patients where the maximum motor blockade 
achieved was Bromage 2.This is in concordance with the study conducted by Saurav 
et al(48) who concluded that the maximum scale of motor block with 0.5% 
levobupivacaine alone ranged between Bromage 1 to 2 as compared to Bromage scale 
between 2-3 achieved with the addition of dexmedetomidine. 
The time taken to achieve the maximum scale of motor block also showed 
statistical significance between the 2 groups in this study with mean time of 27.83 
minutes in group A and 22.17 minutes in group B. This has been found to correlate 
with the study of  Bajwa et al(47) who pointed out that the time taken to achieve the 
maximum motor blockade was shorter with the addition of 50 micrograms of 
dexmedetomidine(17.24+/-5.26 minutes) rather than with levobupivacaine alone. 
6. DURATION OF ANALGESIA 
        The mean duration of  analgesia was found to be highly significant in group 
B(mean time- 477.83 minutes) in comparison to  group A(mean time-351.67 minutes) 
with p value of 0.000. 
  
96 
 
7. DURATION OF SENSORY AND MOTOR BLOCKADE 
Statistical significance has also been found with respect to the duration of  
sensory and motor blockade in the 2 groups, with the additive group showing 
prolonged duration of both sensory and motor blockade. 
Mean durations of sensory blockade(i.e) mean time to complete regression of 
sensory blockade to S1 were 459.5 minutes & 568 minutes in groups A & B 
respectively. Mean durations of  motor blockade(i.e) time taken for complete 
regression of motor blockade to modified Bromage scale 0 were found to be 122.5 
minutes and 265.33 minutes respectively in groups A & B. 
Cox et al(35) and Mantouvalou et al(49) also reported the mean duration of  
sensory blockade to be 460 minutes and the mean duration of motor blockade to be 
122 minutes with 20 ml of 0.5% levobupivacaine used for lower limb surgeries. This 
mean duration of  both sensory & motor blockade increased with the addition of  
dexmedetomidine as studied by Kamal & Talaat et al(45). 
8. HEMODYNAMIC PARAMETERS  
HEART RATE, SYSTOLIC,DIASTOLIC &  MEAN ARTERIAL BLOOD 
PRESSURE 
The fall in heart rate in group B was maximum between 25 minutes to 100 
minutes which showed statistical significance compared to group A. But decrease in 
heart rate more than 20% from the baseline or less than 50 beats/min which needed 
treatment with Inj Atropine was found in 2 out of  30 patients in group B and was not 
found in any of the group A patients which is statistically insignificant. 
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Similarly fall in systolic, diastolic & mean arterial blood pressure in group B 
was maximum from 5 to 60 minutes with statistical significance compared to group 
A. But the fall in systolic blood pressure >20% from baseline or less than 90 mmHg 
which necessitated treatment with Inj Ephedrine was found in 3 patients in group B 
patients as compared to 2 patients in group A which is also statistically not 
significant. Though there was fall in systolic blood pressure <90 mmhg in 3 out of 30 
patients in group B patients, their mean arterial blood pressures never went below 60 
mmHg which correlates with the study conducted by Bajwa et al(47) with the use of 
epidural dexmedetomidine. 
      Also postoperatively, heart rate & blood pressure remained stable in both the 
groups.The stable hemodynamics can be explained on the basis of  the concentration 
of levobupivacaine used and the selection of suitable dose of dexmedetomidine. 
9. SEDATION SCORES 
Epidural administration of dexmedetomidine is associated with sedation, analgesia, 
anxiolysis, hypnosis & sympatholysis. Mean sedation score in group B was 
predominantly found to be 2 as per Ramsay sedation scoring (i.e) arousable to verbal 
commands, at all point of times observed. Absence of respiratory depression is a 
remarkable feature of dexmedetomidine as pointed out by Kamal et al(45). 
10. ADVERSE EFFECTS 
Adverse effects were noted only in 5 out of 30 patients in group A and in 9 patients in 
group B which is statistically non significant. 
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      Among group A patients, nausea, vomiting was reported in 1 patient and urinary 
retention was noted in 2 patients. Among group B patients, dry mouth, nausea & 
vomiting were observed one in each of the patients, shivering in 2 patients. Overall 
30% of the patients in group B experienced adverse effects (including hypotension & 
bradycardia)  which is statistically insignificant as compared to 16.67% in group A 
patients. These findings correlate well with the study conducted by Bajwa SJS, Bajwa 
SK et al(50) where similar adverse effects experienced in both groups were reported to 
be only mildly discomforting to the patients. None of the patients in group B had 
profound deep sedation or respiratory depression with the addition of 
dexmedetomidine. 
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SUMMARY 
The present study compared the effects of addition of epidural 
dexmedetomidine 50 micrograms to epidural 0.5% levobupivacaine for infraumbilical 
and lower limb surgeries. 
Sixty patients of either sex belonging to ASA I & II in the age group of 25-45 
years scheduled for infraumbilical and lower limb surgeries were randomly selected 
and divided into 2 groups A and B.(30 each) 
Group A-30 patients were randomly assigned to receive 0.5% isobaric 
levobupivacaine 20 ml epidurally with 0.5 ml distilled water. 
Group B-30 patients were randomly assigned to receive 0.5% isobaric 
levobupivacaine 20 ml plus 0.5 ml dexmedetomidine containing 50 micrograms. 
This study evaluated the following parameters like time of onset of sensory 
blockade at T10 level, maximum sensory blockade achieved and time taken to 
achieve the same, onset time of motor blockade, degree of motor blockade, time taken 
to achieve maximal motor blockade, hemodynamic changes in pulse rate, blood 
pressure and saturation, side effects and complications, intraoperative sedation scores, 
duration of analgesia, sensory & motor blockade, and any postoperative adverse 
reactions. 
The data obtained from the above parameters in both the groups were 
statistically analysed using “statistical package for social sciences software” and p 
value of <0.05 was considered to be statistically significant. Demographic parameters 
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such as age, sex, weight and height have no statistically significant difference between 
the 2 groups. 
There was statistically significant difference between the 2 groups in maximal 
sensory level achieved. In group A it ranged from T6 to T8 and in group B it ranged 
from T4 to T6.Time of onset of sensory level to T10 and the time taken to achieve the 
maximum  level of sensory blockade was slightly lesser in group B compared to 
group A but showed no statistical significance. 
Mean time of onset of motor blockade and maximum motor blockade 
achieved also showed statistically significant difference between the 2 groups with 
group A showing 19.33 minutes ranging from Bromage scale 1 to 2 as opposed to 
group B showing only 14.5 minutes ranging from Bromage scale 2 to 3. 
Duration of analgesia, sensory and motor blockade were all found to be 
significantly higher in group B(477.3 minutes,568 minutes,265 minutes) as compared 
to group A(351.67 minutes,459.5 minutes,122.5 minutes)respectively. 
Adverse effects experienced in general were statistically insignificant in both 
the groups. Mean sedation score in group B (Dexmedetomidine group) was 
predominantly found to be 2 as per Ramsay sedation score. None of the patients in 
group B had deep sedation or profound respiratory depression. 
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CONCLUSION 
This study concludes that combining dexmedetomidine 50 micrograms with 
0.5% isobaric levobupivacaine epidurally helps in achieving maximal sensory level of 
T4 to T6.Also the onset time of motor blockade was shortened  with the addition of 
dexmedetomidine and the maximal motor blockade achieved was also intense with 
dexmedetomidine. Duration of analgesia, sensory and motor blockade were prolonged 
when levobupivacaine is combined with dexmedetomidine epidurally. Changes in 
hemodynamic parameters (blood pressure & heart rate) were very minimal in the 
dexmedetomidine group. Adverse effects encountered with dexmedetomidine were 
also acceptable with only mild discomfort to the patients. Absence of respiratory 
depression is a remarkable feature of dexmedetomidine. 
  Therefore combination of epidural dexmedetomidine with 0.5% isobaric 
levobupivacaine provides a better anaesthetic outcome in various aspects studied with 
minimal side effects than epidural 0.5% isobaric levobupivacaine alone.
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PROFORMA 
Name:  
Age:  
Sex: 
IPno: 
Group: 
Date of admission:      Date of surgery: 
Preoperative  examination: 
Blood pressure: 
Pulse rate : 
Room air SpO2: 
Cardiovascular system: 
Respiratory system: 
Central nervous system:  
Diagnosis:                                                                                                 
Surgery being performed:     ASA: 
Investigations:   
  
Premedication:  
Time of injection of study drug: 
Time of onset of sensory block at T10 level: 
Time of onset of motor blockade:  
Maximum sensory blockade achieved & time taken: 
Maximum motor blockade achieved (by modified Bromage scale): 
Total duration of analgesia: 
Total duration of sensory blockade: 
Total duration of motor blockade: 
Time of rescue analgesia & drug given: 
Postoperative adverse effects if any: 
 
  
  
INTRAOPERATIVE PARAMETERS: 
 
 
  
Time 
Intervel in 
Minutes 
HR SpO2 SBP DBP MAP Drug used 
Basal       
1 min        
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15 
 
      
20 
 
      
25       
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80       
90       
100       
110       
120       
  
 
 
 
HR-Heart rate; SBP-Systolic blood pressure; DBP-Diastolic blood pressure; 
MAP-Mean arterial pressure. 
  
 80 mins 90 mins 100 mins 110 mins 120 mins 
HR      
SpO2      
SBP      
DBP      
MAP      
Drug used      
 Sedation score 
Baseline  
30  
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120  
  
PATIENT CONSENT FORM 
Study detail : A Comparative study of epidural 0.5% isobaric 
Levobupivacaine  and epidural  0.5% isobaric  
Levobupivacaine with Dexmedetomidine for patients 
undergoing elective infraumbilical and lower limb surgeries. 
Study centre :  GOVT. KILPAUK  MEDICAL  COLLEGE HOSPITAL  & 
GOVT.  ROYAPETTAH HOSPITAL , CHENNAI. 
Patient’s Name  : 
Patient’s Age   : 
Identification Number : 
Patient may check () these boxes 
 I  confirm that I have understood the purpose of procedure for the above study. I 
have the opportunity to ask question and all my questions and doubts have been 
answered to my complete satisfaction. 
 I understand that my participation in the study is voluntary and that I am free to 
withdraw at any time without giving reason, without my legal rights being affected. 
 I agree to take part in the above study and to comply with the instructions given 
during the study and faithfully cooperate with the study team and to immediately 
inform the study staff if I suffer from any deterioration in my health or well-being 
or any unexpected or unusual symptoms. 
 I hereby consent to participate in this study. 
  I hereby give permission to undergo complete clinical examination and diagnostic 
tests including hematological, biochemical, radiological tests. 
Signature/thumb impression:    
Patients Name and Address:                        
Place:   Date: 
Signature of investigator : 
Study investigator’s Name :                                                                                                                      
  
 
  
  
MASTER CHART KEYWORDS 
DUR  - Duration 
HR  - Heart Rate 
SBP  - Systolic Blood Pressure 
DBP  - Diastolic Blood Pressure 
MAP  - Mean arterial Blood Pressure 
SB  - Sensory Blockade 
MB  - Motor Blockade 
Analg  - Analgesia 
Sscore - Sedation Score 
SpO2  - Oxygen Saturation 
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1 EGAMBARAM 23847 41 M A 168 60 PS I LT HYDROCELE WITH PHIMOSIS  LEFT SAC EVERSION WITH CIRCUMCISION 90 15 T8  20 20 BR 2 25 240 330 150 NIL 
2 GOPALAKRISHNAN 23946 42 M A 170 68 PS I B/L INDIRECT INGUINAL HERNIA B/L HERNIOPLASTY 100 12 T6 20 15 BR 3 25 390 480 120 NIL 
3 DEVADARSAN 1409334 33 M A 170 76 PS I RT INGUINAL HERNIA RIGHT HERNIOPLASTY 70 22 T6 30 30 BR 2 40 240 360 90 NIL 
4 MUNNUSAMY 1409300 35 M A 164 62 PS I LT INGUINAL HERNIA WITH LTHYDROCELE LEFT HERNIOPLASTY WITH LT SAC EVERSION 110 14 T6 22 25 BR 2 35 380 480 120 NIL 
5 JAYAKODI 1410123 30 F A 158 54 PS I LEFT FEMORAL HERNIA LEFT HERNIOPLASTY 120 6 T6 16 10 BR 3 20 370 450 150 NIL 
6 DAMODARAN 1410784 40 M A 164 62 PS I B/L HYDROCELE B/L SAC EVERSION 70 10 T6 14 15 BR 3 20 365 495 120 NIL 
7 MEERA 1410892 43 F A 155 54 PSII INCISIONAL HERNIA MESH REPAIR 70 8 T6 16 10 BR 3 20 240 375 120 NIL 
8 LAKSHMI 1410906 35 F A 154 52 PSI UMBILICAL HERNIA MESH REPAIR 100 14 T4  24 20 BR 2 35 420 540 90 URINARY RETENTION 
9 BAKRUDDIN 1454725 38 M A 166 60 PS I LEFT HYDROCELE LEFT SAC EVERSION 70 16 T6 22 20 BR 2 30 375 465 105 NIL 
10 VADIVEL 1456452 40 M A 160 58 PSII RT INGUINAL HERNIA WITH RT HYDROCELE  RT HERNIOPLASTY WITH RT SACEVERSION 100 16 T6 26 25 BR 2 35 390 480 120 NIL 
11 KAALI 1414564 28 M A 162 64 PS I SUBACUTE APPENDICITIS OPEN APPENDICECTOMY 70 14  T4 22 20 BR 3 30 270 420 120 NIL 
12 ARUL 1412462 36 M A 166 62 PS I INCISIONAL HERNIA ANATOMICAL REPAIR 90 12 T6 20 15 BR 2 25 390 510 90 NIL 
13 MOHAN 1414565 26 M A 167 70 PS I RAW AREA RT FOOT SSG 100 10 T6 20 15 BR 2 20 330 420 150 NIL 
14 JOTHI 1414567 32 F A 165 60 PS I INCISIONSL HERNIA MESH REPAIR 90 16 T8 20 20 BR 3 25 300 450 120 NIL 
15 SUNDARAM 1414602 32 M A 169 67 PS I B/L  INDIRECT HERNIA B/L  HERNIOPLASTY 120 10 T8 16 15 BR 3 25 360 480 150 NIL 
16 DINESH 1414539 29 M A 169 66 PS I AZOOSPERMIA LT VARICOCELECTOMY 90 8 T6 16 20 BR 3 30 405 480 120 NIL 
17 MAHESHWARI 1415474 32 F A 160 62 PS I RT FEMORAL HERNIA RT   HERNIORRHAPHY 70 12 T6 18 20 BR 3 20 375 510 150 NIL 
18 ELUMALAI 1414567 40 M A 166 58 PS II LT HAEMATOCELE LT SAC EVERSION WITH DRAINAGE 70 16 T6 26 25 BR 2 35 390 480 90 NIL 
  
19 SAIRAM 1414752 39 M A 165 63 PS I LT INGUINAL HERNIA LT HERNIO PLASTY 80 12 T6 16 20 BR 2 30 330 420 90 NIL 
20 SEKAR 1450745 30 M A 167 69 PS I RT HYDROCELE RT SAC EVERSION 70 14 T6 18 20 BR 2 25 270 420 90 NIL 
21 SAMSON 1415247 32 M A 166 64 PS I RAW AREA LT LEG SSG AND FLAP COVER 90 14 T6 20 20 BR 2 25 330 420 90 NAUSEA,VOMITING 
22 MAHALAKSHMI 1414562 40 F A 158 54 PS I RT RECURRENT INGINAL HERNIA  RT HERNIOPLASTY 90 8 T8 16 15 BR 3 30 360 480 150 NIL 
23 RAJESH 1415674 34 M A 160 57 PS I INCISIONAL HERNIA MESH PLASTY 90 14 T8 20 20 BR 3 30 405 480 120 NIL 
24 KASTHURI 1414567 38 F A 164 62 PS I SUBACUTE APPENDICITIS OPEN APPENDICECTOMY 90 16 T6 20 20 BR 2 25 390 480 150 URINARY RETENTION 
25 SAKTHIVEL 1414562 26 M A 166 60 PS I RT INGUINAL HEERNIA RT HERNIOPLASTY 80 16 T8 22 20 BR 2 30 300 420 120 NIL 
26 ANAND 1415672 34 M A 163 64 PS I LT HYDROCELE WITH PHIMOSS  LT SAC EVERSION WITH CIRCUMCISION 70 9 T6 20 20 BR 2 30 360 450 120 NIL 
27 SUKUMAR 1413567 37 M A 165 64 PS I RT INGUINAL HERNIA  WITH RT HYDROCELE  RT HERNIOPLASTY WITH RT SAC EVERSION  70 12 T6 16 25 BR 3 30 390 480 150 NIL 
28 GANESH 1454765 31 M A 167 64 PS I B/L HYDROCELE B/L SAC EVERSION 70 12 T6 20 20 BR 2 30 420 540 120 NIL 
29 SAIRABANU 1414567 40 F A 160 57 PSII INCISIONAL HERNIA ANATOMICAL REPAIR 90 6 T6  16 15 BR 2 20 405 510 180 NIL 
30 GOPI 1414325 42 M A 164 60 PS II RECURRENT INCISIONAL  HERINA MESH REPAIR 80 10 T6  18 25 BR 2 35 360 480 120 URINARY RETENTION 
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1 
BALAMURUGA
N 5666 25 M B 168 64 PS 1 LEFT VARICOSE VEINS 
LEFT TRENDELENBERG 
PROCEDURE 80 12 T4 22 20 BR 2 30 405 540 240 
DRY 
MOUTH 1 2 2 2 2 
2 NIXON 1410154 32 M B 166 59 PS 1 CHRONIC APPENDICITIS OPEN APPENDICECTOMY 70 14 T4 26 15 BR 3 25 460 540 255 NIL 1 2 2 2 2 
3 SURESH 1410168 28 M B 165 66 PS 1 SUBACUTE APPENDICITIS OPEN APPENDICECTOMY 70 12 T6 20 20 BR 3 30 480 555 280 
NAUSEA
,VOMITI
NG 1 2 2 2 2 
4 MURUGAN 1411245 35 M B 166 68 PS 1 RIGHT INGUINAL HERNIA RIGHT HERNIOPLASTY 100 10 T6 22 20 BR 3 25 480 600 300 NIL 1 2 2 2 2 
5 LAKSHMANAN 1411276 31 M B 168 67 PS 1 
RIGHT INGUINAL HERNIA WITH 
FISSURE IN ANO 
RIGHT HERNIOPLASTY WITH 
LATERAL SPHINCTEROTOMY 110 12 T4 22 15 BR 3 25 420 510 315 NIL 1 2 2 2 2 
  
6 RAVI 1412020 45 M B 166 60 PS II UMBILICAL HERNIA ANATOMICAL REPAIR 70 8 T4 12 10 BR 3 15 525 600 240 NIL 1 1 2 2 2 
7 THANUJA 14123452 36 F B 156 52 PS I INCISIONAL HERNIA ANATOMICAL REPAIR 120 10 T4 20 15 BR 3 20 600 720 300 
SHIVER
ING 1 1 1 2 2 
8 GOWRI 1414068 40 F B 162 59 PSI INCISIONAL HERNIA MESH REPAIR 60 8 T4 14 10 BR 3 15 480 570 270 NIL 1 2 2 2 2 
9 SUKUMAR 1414542 26 M B 167 54 PS I RT VARICOSE VEINS 
RT TRENDELENBERG 
OPERATION 120 10 T4 14 10 BR 2 15 420 495 300 NIL 1 2 2 2 2 
10 SHANKAR 14`6478 32 M B 166 64 PS I 
POST TRAUMATIC RAW AREA RT 
LEG FLAP COVER 80 12 T6 16 15 BR 2 15 450 540 270 NIL 1 2 2 2 1 
11 SHANMUGAM 1401567 40 M B 164 62 PS II LT HYDROCELE WITH PHIMOSIS 
LT SAC EVERSION WITH 
CIRCUMCISION 100 16 T6 22 15 BR 3 25 450 540 210 NIL 1 1 2 2 1 
12 VENKATESAN 1416752 38 M B 169 64 PS I B/L INGUINAL HERNIA B/L HERNIOPLASTY 100 22 T4 30 20 BR 2 30 420 570 270 
SHIVER
ING 1 2 3 2 2 
13 SHAKTHI 1412567 35 F B 162 59 PS I FEMORAL HERNIA HERNIORRHAPHY 60 8 T4 16 15 BR 2 20 510 570 300 NIL 1 2 3 2 1 
14 MALATHI 1410564 44 F B 156 50 PS II LIPOMA RT THIGH EXCISION 80 10 T6 14 10 BR 3 25 480 540 270 NIL 1 1 2 2 1 
15 VELMURUGAN 1424562 30 M B 169 64 PS I B/L HYDROCELE B/L SAC EVERSION 60 12 T4 20 15 BR 3 20 510 600 300 NIL 1 2 3 2 1 
16 SURENDRAN 1410462 34 M B 169 62 PS I B/L VARICOSE VEINS 
B/L TRENDELENBERG 
PROCEDURE 135 14 T6 18 15 BR 3 25 465 540 330 NIL 1 2 3 2 2 
17 SAKTHI 1415647 35 M B 170 67 PS I AZOOSPERMIA RT VARICOCELECTOMY 80 10 T6 16 10 BR 3 20 540 600 300 NIL 1 2 2 2 1 
18 KALPANA 1410562 27 F B 162 54 PSI 
LT RECURRENT INGUINAL 
HERNIA LT MESH PLASTY 100 8 T6 12 10 BR 3 20 510 600 270 NIL 1 2 3 2 2 
19 SEKAR 1414742 42 M B 169 63 PS II 
POST TRAUMATIC RAW AREA LT 
THIGH SSG 90 8 T4 16 15 BR 3 20 540 630 270 NIL 1 2 2 2 2 
20 PRABHU 1414562 40 M B 166 60 PS II 
LT INGUINAL HERNIA WITH B/L 
HYDROCELE 
LT HERNIOPLASTY WITH B/L 
SAC EVERSION 90 12 T6 16 15 BR 3 20 480 540 300 NIL 1 2 2 2 2 
21 NATHAN 1415672 39 M B 167 62 PS I LT  TESTICILAR TUMOUR LT ORCHIDECTOMY 100 6 T4 12 10 BR 3 15 525 600 210 NIL 1 2 2 2 2 
22 SHAAHEERA 1415725 32 F B 158 57 PS I INCISIONAL HERNIA ANATOMICAL REPAIR 110 10 T6 18 10 BR 3 20 465 510 180 NIL 1 2 2 3 2 
23 RAJAN 1414562 28 M B 168 64 PS I SUBACUTE APPENDICITIS OPEN APPENDICECTOMY 70 8 T4 18 15 BR 3 25 420 510 210 NIL 1 2 3 2 2 
24 BABU 1414254 42 M B 166 63 PS I RT HYDROCELE WITH PHIMOSIS 
RT SAC EVERSION WITH 
CIRCUMCISION 70 12 T6 10 15 BR 3 25 450 600 240 NIL 1 2 2 2 1 
25 MARIMUTHU 1414567 32 M B 166 59 PS I RT INGUINAL HERNIA RT HERNIOPLASTY 70 14 T4 20 20 BR 3 25 420 570 270 NIL 1 2 2 2 1 
26 SANTHANAM 1414589 34 M B 168 70 PS I B/L HYDROCELE B/L SAC EVERSION 70 14 T6 20 15 BR 3 25 495 600 240 NIL 1 2 3 2 1 
27 SHANTHI 1414752 35 F B 164 59 PSI CHRONIC APPENDICITIS OPEN APPENDICECTOMY 70 12 T6 16 15 BR 3 20 510 570 270 NIL 1 2 2 2 2 
28 SRINIVASAN 1414754 34 M B 170 68 PSI LTVARICOSE VEINS 
LT TRENDELENBERG 
PROCEDURE 100 14 T4 20 15 BR 3 25 480 570 270 NIL 1 2 3 2 1 
29 SHANKARI 1414562 39 F B 160 56 PSI INCISIONAL HERNIA MESH PLASTY 90 14 T4 20 10 BR 3 20 450 540 240 NIL 1 2 3 2 1 
30 
MUTHUKARUP
PAN 1415647 29 M B 169 60 PSI UMBILICAL HERNIA 
ANATOMICAL REPAIR WITH 
UMBILICECTOMY 70 10 T4 20 20 BR 2 25 495 570 240 NIL 1 2 2 2 2 
  
 
Patient GROUP A HR_base HR_1m HR_5m HR_10m HR_15m HR_20 m HR_25 m HR_30 m HR_40 m HR_50m HR_60m HR_70m HR_80 m HR_90m HR_100m HR_110m HR_120m SB_base SB_1m SB_5m SB_10m SB_15m SB_20 m SB_25 m SB_30 m SB_40 m SB_50m SB_60m SB_70m SB_80 m SB_90m SB_100m SB_110m SB_120m 
1 EGAMBARAM 90 86 82 78 76 78 74 72 76 76 74 70 72 74 76 74 72 140 142 138 122 124 122 122 134 140 142 132 136 132 140 130 132 134 
2 GOPALAKRISHNAN 72 74 68 66 64 60 64 68 64 66 60 62 62 64 66 68 64 130 128 120 110 108 108 118 118 118 120 122 118 120 118 122 124 126 
3 DEVADARSAN 78 80 74 72 72 70 72 70 66 66 68 64 64 64 66 66 64 130 132 128 124 120 118 122 118 120 114 112 114 124 120 118 116 122 
4 MUNNUSAMY 78 82 74 74 72 68 64 62 60 62 64 68 60 64 62 62 64 120 122 130 110 108 114 92 88/E6 110 106 110 112 116 114 112 118 120 
5 JAYAKODI 64 62 64 68 62 66 66 68 66 58 56 62 68 70 70 72 68 102 102 100 102 100 100 102 106 104 104 80/E6 102 94 112 110 114 106 
6 DAMODARAN 78 80 74 72 74 70 68 66 62 64 64 68 66 64 68 66 72 140 136 142 130 132 140 142 138 132 134 136 134 130 134 132 134 134 
7 MEERA 80 86 84 78 76 76 74 72 72 74 74 70 76 74 76 72 70 120 124 118 114 110 104 106 108 100 98 96 104 100 102 104 104 102 
8 LAKSHMI 80 84 78 82 76 72 68 64 62 68 72 74 76 76 78 78 76 130 128 114 110 110 104 102 100 100 100 100 104 102 104 104 106 104 
9 BAKRUDDIN 84 88 84 86 80 78 78 76 74 76 74 78 80 82 84 82 80 120 120 120 118 113 112 112 110 112 110 108 110 108 108 110 112 110 
10 VADIVEL 84 88 86 84 80 78 76 80 78 78 74 72 68 70 68 68 70 132 130 128 124 122 118 116 114 110 112 110 112 110 112 110 1118 116 
11 KAALI 90 94 92 88 86 84 80 82 80 82 78 78 76 76 78 78 76 118 120 122 120 122 118 112 110 108 108 106 108 112 110 114 112 114 
12 ARUL 84 88 82 80 78 80 76 78 80 76 74 74 76 74 72 74 75 112 110 110 112 110 108 106 108 110 108 106 104 104 102 106 104 106 
13 MOHAN 82 86 82 80 82 76 76 78 74 72 70 74 72 70 70 70 74 114 110 108 106 104 102 100 102 102 104 108 108 106 108 104 102 108 
14 JOTHI 86 84 80 82 80 80 78 74 70 76 74 70 70 72 76 78 76 124 122 120 118 116 112 110 112 110 108 110 110 108 110 112 110 106 
15 SUNDARAM 80 86 82 78 78 80 76 74 74 76 72 74 70 70 72 68 72 110 110 108 106 106 104 104 106 106 104 102 102 106 102 102 102 104 
16 DINESH 86 88 84 82 80 78 78 76 80 76 82 78 72 70 72 74 76 130 130 128 124 122 122 120 118 116 114 112 110 108 106 108 110 112 
17 MAHESHWARI 88 90 86 88 82 80 82 80 84 78 76 78 78 76 76 76 78 124 118 116 114 112 110 110 108 108 110 110 110 114 112 116 118 110 
18 ELUMALAI 86 90 85 84 80 82 78 80 76 74 70 72 72 76 76 80 82 124 122 120 120 112 110 108 110 108 106 108 106 104 106 104 108 106 
19 SAIRAM 82 88 84 82 86 78 82 76 74 72 70 72 74 76 78 76 78 110 112 110 108 108 106 108 110 106 104 100 100 102 100 104 106 106 
20 SEKAR 94 96 90 88 92 86 84 80 82 80 82 80 84 86 88 86 84 120 118 116 114 110 112 108 106 108 106 104 102 108 112 106 110 112 
21 SAMSON 92 96 98 90 86 88 84 80 82 80 76 78 76 74 76 76 78 114 116 114 112 110 108 106 104 104 102 104 102 102 104 110 112 110 
22 MAHALAKSHMI 90 88 86 88 84 80 74 70 72 70 68 70 70 72 74 76 78 118 120 122 120 116 116 112 110 106 104 106 102 100 102 108 106 108 
23 RAJESH 80 82 76 78 70 74 76 70 68 64 66 70 72 70 78 76 78 110 114 112 108 106 104 102 102 98 96 100 100 102 104 106 108 106 
24 KASTHURI 90 94 92 88 86 80 82 82 84 80 78 76 78 76 78 76 76 122 120 118 116 110 112 108 106 110 110 108 106 108 106 114 120 118 
25 SAKTHIVEL 86 90 88 84 82 80 82 78 76 74 70 74 72 80 78 78 76 130 128 124 122 120 118 112 110 110 112 108 110 110 112 114 112 110 
26 ANAND 84 88 86 80 82 78 74 76 72 70 72 70 72 73 76 76 80 130 128 124 118 116 114 112 110 110 108 108 106 108 106 104 104 112 
27 SUKUMAR 86 88 90 84 80 82 80 82 76 78 74 70 74 76 78 78 76 120 122 118 114 112 110 108 108 106 108 108 106 110 112 114 120 122 
28 GANESH 88 92 90 86 84 82 80 76 74 70 68 70 72 76 78 76 82 124 122 120 118 116 114 112 110 108 106 108 106 110 112 110 120 122 
29 SAIRABANU 92 96 90 92 88 86 80 82 78 80 76 74 76 74 78 84 82 140 138 134 130 128 128 124 130 128 124 122 120 122 120 124 126 126 
30 GOPI 78 84 82 80 76 76 80 74 70 72 68 66 70 72 74 76 78 120 118 112 110 112 108 110 108 110 106 102 100 102 104 106 104 108 
 GROUP B                                   
1 BALAMURUGAN 92 88 84 78 72 66 62 68 70 76 72 70 78 78 76 78 76 132 138 136 132 136 138 134 142 134 132 124 138 142 132 130 128 126 
2 NIXON 88 82 76 70 60 56 54 56 54 58 60 60 64 62 64 68 72 132 140 136 140 130 128 126 124 122 120 122 120 122 124 126 122 130 
3 SURESH 92 94 86 78 64 62 66 64 66 64 62 60 62 66 64 64 66 132 130 132 128 124 122 122 118 120 124 124 122 126 126 124 122 122 
4 MURUGAN 82 86 80 78 72 66 62 56 52 48/A0.6 52 56 60 62 64 64 64 124 126 118 116 118 110 108 110 102 100 104 108 118 120 120 120 118 
5 LAKSHMANAN 86 90 92 84 78 72 68 66 64 62 64 66 68 70 68 72 74 122 120 124 120 122 114 116 120 118 120 114 118 120 122 126 124 126 
6 RAVI 98 102 92 88 82 82 80 78 74 70 72 70 72 74 76 74 74 130 120 110 114 110 100 90 110 114 108 104 106 110 112 114 110 112 
7 THANUJA 98 96 92 88 84 78 74 72 66 64 62 66 60 62 64 62 66 120 124 114 110 104 100 94 92 92 96 104 102 100 100 102 104 102 
8 GOWRI 112 104 100 96 94 90 88 84 84 86 84 84 84 86 84 80 82 130 120 96 80/E6 90 92 94 100 102 110 102 102 98 98 100 102 100 
9 SUKUMAR 86 90 84 82 78 76 72 70 68 64 64 62 62 58 60 62 60 124 120 118 112 110 106 108 100 92 88 96 100 102 104 108 104 104 
10 SHANKAR 80 84 62 80 74 74 70 70 64 56 56 58 74 76 72 74 74 122 126 120 114 112 110 100 102 92 96 96 100 102 108 106 98 104 
11 SHANMUGAM 80 82 78 72 68 64 62 56 52 48 60 62 62 64 60 62 64 112 114 110 98 94 92 86/E6 98 100 90 96 102 104 102 102 106 108 
12 VENKATESAN 90 92 94 88 82 76 72 68 70 66 68 64 66 62 64 66 64 120 124 118 108 104 102 98 92 90 100 102 104 102 108 110 112 108 
13 SHAKTHI 78 84 80 74 72 68 84 58 50 56 58 60 60 64 62 64 64 130 122 110 108 110 102 100 100 102 96 96 98 100 104 106 102 112 
14 MALATHI 94 98 90 86 80 80 62 76 74 72 70 68 64 66 66 68 72 110 112 108 110 102 104 98 96 92 90 100 102 100 104 106 108 110 
15 VELMURUGAN 86 90 88 86 80 82 76 74 68 62 60 62 64 66 64 65 66 124 118 110 112 100 104 102 106 98 92 104 106 108 104 104 102 104 
16 SURENDRAN 90 94 98 90 86 82 78 74 70 62 64 60 62 60 64 58 62 120 4 112 106 102 96 90 92 94 102 104 106 104 102 104 100 100 
17 SAKTHI 78 82 80 74 72 72 70 64 62 56 56 58 56 60 62 64 68 120 118 112 108 106 98 92 92 90 94 98 100 102 100 102 98 104 
18 KALPANA 86 90 88 84 80 82 76 70 64 62 60 60 58 60 62 66 64 110 116 108 106 98 96 90 92 84 90 108 104 102 100 104 106 108 
19 SEKAR 92 96 90 88 86 84 78 70 64 60 58 56 60 58 62 65 64 130 128 118 110 100 98 92 94 92 90 84/E6 96 102 100 104 106 108 
20 PRABHU 80 86 90 82 76 74 70 62 54 54 48/A.06 58 60 62 60 62 64 124 118 110 102 98 90 96 94 98 96 94 100 102 102 104 106 106 
21 NATHAN 78 84 80 72 64 62 60 58 56 54 54 56 54 54 56 58 62 118 120 112 108 102 98 100 102 98 100 100 102 102 102 104 106 106 
22 SHAAHEERA 88 94 86 84 84 86 80 76 70 64 66 68 64 62 60 62 64 118 120 110 108 106 104 102 98 96 94 96 92 90 94 98 98 102 
23 RAJAN 96 98 92 88 86 82 80 78 70 68 64 62 64 64 66 66 68 120 120 118 116 114 108 106 102 104 102 100 102 104 106 108 110 112 
24 BABU 86 84 88 80 76 72 72 68 62 60 58 58 60 62 64 64 66 110 112 108 104 108 106 108 102 98 96 94 96 98 98 108 110 108 
25 MARIMUTHU 90 98 102 94 92 86 82 76 70 64 68 62 70 70 72 74 75 122 118 110 108 108 106 104 102 108 110 110 106 108 108 110 104 112 
26 SANTHANAM 80 84 88 80 74 72 70 66 64 58 58 60 64 66 72 74 74 124 122 116 110 110 108 106 104 106 102 100 98 100 100 110 112 110 
27 SHANTHI 86 92 86 84 80 78 82 74 68 62 60 64 66 68 66 66 68 112 114 110 108 108 104 104 102 102 100 102 102 106 108 110 114 112 
28 SRINIVASAN 84 88 86 80 76 74 70 66 68 62 58 60 60 62 60 62 66 112 114 110 108 104 102 98 92 90 92 90 86 98 102 102 106 108 
29 SHANKARI 82 84 86 80 82 80 76 70 68 68 64 62 60 58 68 68 70 120 120 120 118 112 110 108 106 106 102 102 100 98 102 108 110 118 
30 MUTHUKARIPPAN 78 82 84 80 76 74 70 70 68 64 62 64 68 74 78 80 82 130 128 124 122 110 110 108 106 102 100 102 98 104 104 108 110 112 
  
INTRAOPERATIVE  PARAMETERS 
  
 
Patient GROUP A DB_base DB_1m DB_5m DB_10m DB_15m DB_20 m DB_25 m DB_30 m DB_40 m DB_50m DB_60m DB_70m DB_80 m DB_90m DB_100m DB_110m DB_120m MAP_base MAP_1m MAP_5m MAP_10m MAP_15m MAP_20 m MAP_25 m MAP_30 m MAP_40 m MAP_50m MAP_60m MAP_70m MAP_80 m MAP_90m MAP_100m MAP_110m 
1 EGAMBARAM 80 72 76 86 78 86 82 86 82 84 84 88 84 86 84 84 86 100 97 97 98 93 98 95 102 101 103 100 98 100 104 98 96 
2 GOPALAKRISHNAN 80 78 70 70 68 62 76 64 76 80 80 78 80 68 74 78 78 97 95 87 83 81 77 90 82 90 93 94 91 93 85 90 92 
3 DEVADARSAN 76 80 74 70 82 76 78 82 68 70 80 72 74 74 76 78 78 94 97 92 88 95 90 93 94 85 85 91 86 88 84 82 84 
4 MUNNUSAMY 70 72 74 68 64 60 56 52 70 70 68 62 70 72 76 70 72 87 89 93 82 79 78 68 64 83 82 82 79 85 86 88 86 
5 JAYAKODI 72 70 62 74 68 62 64 76 68 68 54 64 68 60 60 70 68 82 81 75 83 79 75 77 86 80 80 63 77 77 77 80 85 
6 DAMODARAN 82 86 80 70 68 70 76 62 70 68 62 64 66 68 68 66 68 101 103 101 90 89 93 98 87 91 90 87 88 86 84 86 88 
7 MEERA 70 72 68 68 62 60 62 64 56 54 52 62 62 62 62 68 64 87 89 85 83 78 75 77 79 71 69 67 76 75 75 76 80 
8 LAKSHMI 70 72 68 70 68 62 64 62 68 70 72 72 72 76 72 74 76 90 91 83 83 82 76 77 75 79 80 85 83 82 85 83 84 
9 BAKRUDDIN 72 74 78 74 72 68 68 70 72 74 72 70 72 72 74 76 78 88 90 92 89 87 83 83 83 85 86 84 83 82 80 78 84 
10 VADIVEL 70 68 70 72 68 70 72 74 64 68 70 70 68 64 72 74 76 91 89 89 89 86 86 87 87 79 83 83 84 82 80 85 84 
11 KAALI 74 74 70 68 64 66 62 60 64 62 60 64 66 64 72 70 72 89 89 87 85 83 83 79 77 79 77 75 79 80 82 83 82 
12 ARUL 80 78 82 80 70 74 76 70 70 68 62 66 66 68 70 72 74 91 89 91 91 83 85 86 83 83 81 77 79 79 79 80 82 
13 MOHAN 82 84 78 74 72 74 68 64 66 64 66 64 66 68 64 68 76 93 93 88 85 83 83 79 77 78 77 80 79 79 81 77 80 
14 JOTHI 80 82 76 72 70 72 68 64 62 62 60 62 58 60 64 66 68 95 95 91 87 85 85 82 80 78 77 77 78 75 77 76 78 
15 SUNDARAM 62 64 62 64 68 62 68 62 64 60 60 62 64 60 60 56 60 78 79 77 78 81 76 80 77 78 75 74 75 78 74 74 71 
16 DINESH 80 78 74 72 68 64 68 70 72 68 62 64 70 62 64 66 68 97 95 92 89 86 83 85 86 87 83 79 79 83 77 78 80 
17 MAHESHWARI 72 70 68 70 68 62 60 60 56 60 62 60 64 68 70 72 76 89 86 84 85 83 78 77 76 73 77 78 77 78 80 82 84 
18 ELUMALAI 78 74 76 78 70 68 62 64 62 68 70 72 76 72 70 72 74 93 90 91 92 84 82 77 79 77 81 83 83 78 80 82 78 
19 SAIRAM 68 70 72 64 62 64 68 62 56 52 50 54 58 62 64 66 70 82 84 85 79 77 78 81 78 73 69 67 69 73 74 76 78 
20 SEKAR 82 80 78 72 78 80 76 72 70 68 64 66 72 74 78 76 74 95 93 91 86 89 91 87 83 83 81 77 78 77 78 80 82 
21 SAMSON 82 84 80 78 74 70 68 68 66 64 62 60 64 66 68 66 68 93 95 91 89 86 83 81 80 79 77 76 74 77 79 80 82 
22 MAHALAKSHMI 76 74 72 68 64 66 62 60 56 54 56 52 60 62 64 66 68 90 89 89 85 81 83 79 77 73 71 73 69 73 75 78 78 
23 RAJESH 84 86 70 64 62 60 62 60 56 54 56 58 54 56 62 64 66 93 95 84 79 77 75 75 74 70 68 71 72 70 72 72 76 
24 KASTHURI 70 60 62 60 60 58 56 52 54 56 60 62 66 62 64 68 66 87 85 81 79 77 76 73 70 73 74 76 77 80 77 78 78 
25 SAKTHIVEL 76 76 70 68 64 62 64 66 64 60 60 62 60 62 64 68 70 94 93 88 86 83 81 80 81 79 77 76 78 77 78 76 74 
26 ANAND 62 64 60 58 56 56 58 52 52 50 54 54 58 56 58 60 62 85 85 81 78 76 75 76 71 71 69 72 71 76 78 74 76 
27 SUKUMAR 74 76 70 68 62 60 60 62 64 62 60 62 64 66 68 64 66 89 91 86 83 79 77 76 77 78 77 76 77 76 78 79 79 
28 GANESH 82 80 76 72 70 68 62 60 56 62 64 52 56 58 60 62 64 96 94 91 87 85 83 79 77 73 77 79 77 78 82 83 84 
29 SAIRABANU 70 72 68 70 64 68 66 62 60 62 64 64 66 68 72 70 74 96 94 90 90 85 88 85 65 83 83 83 83 85 85 84 80 
30 GOPI 70 72 68 64 62 60 56 54 58 56 60 60 54 58 62 66 68 87 87 83 79 79 76 74 72 75 73 74 73 70 72 74 76 
 GROUP B                                  
1 BALAMURUGAN 84 82 78 72 76 84 74 84 86 84 88 84 74 78 76 80 76 103 101 97 92 96 102 94 100 102 100 100 102 97 96 94 92 
2 NIXON 78 82 78 72 62 68 64 62 68 66 68 64 66 64 62 70 74 96 101 97 95 85 88 85 83 86 84 86 83 86 86 88 84 
3 SURESH 78 84 76 80 72 70 80 82 86 78 78 68 70 72 76 74 74 96 99 95 96 89 87 94 94 97 93 93 86 88 90 86 90 
4 MURUGAN 72 82 76 64 62 60 60 56 58 60 60 62 66 68 70 72 74 89 97 90 81 81 77 76 74 73 73 75 77 83 85 89 78 
5 LAKSHMANAN 84 86 78 70 68 76 60 62 76 64 68 62 72 78 82 84 80 97 97 93 87 86 89 79 81 90 83 63 81 88 96 97 97 
6 RAVI 70 84 76 72 68 64 60 70 62 72 70 72 74 76 74 72 70 90 96 87 86 82 76 70 83 79 84 81 83 84 85 86 86 
7 THANUJA 72 70 68 60 56 52 50 52 54 56 60 64 68 70 64 64 64 88 88 83 77 72 68 65 64 67 69 75 77 79 80 77 77 
8 GOWRI 72 62 60 50 54 56 60 60 60 64 60 56 58 60 64 66 62 91 81 72 60 66 68 71 73 74 79 74 71 74 76 78 76 
9 SUKUMAR 76 68 64 62 56 56 52 56 52 50 56 60 62 64 64 66 68 92 85 82 79 74 73 71 71 65 63 69 73 75 77 79 79 
10 SHANKAR 68 70 68 62 60 56 62 64 48 60 62 60 56 58 62 66 64 89 89 85 79 77 74 75 77 63 72 73 73 74 76 78 77 
11 SHANMUGAM 84 76 68 62 56 60 52 60 60 58 60 62 68 70 68 72 68 93 89 82 74 69 71 63 73 73 69 72 75 80 81 79 78 
12 VENKATESAN 68 70 58 56 52 50 52 52 50 56 60 60 64 66 62 64 64 89 88 78 73 69 67 67 65 63 71 74 75 77 80 78 79 
13 SHAKTHI 70 60 56 58 60 56 54 54 58 50 52 54 56 62 64 66 68 90 81 74 75 77 71 69 69 73 65 65 68 72 74 76 75 
14 MALATHI 60 68 60 54 56 56 58 52 54 56 62 58 62 64 66 64 66 77 83 76 69 71 72 71 67 67 67 75 73 75 70 72 71 
15 VELMURUGAN 82 76 62 56 58 60 64 68 70 50 58 64 66 68 70 72 74 96 90 78 71 72 75 77 81 79 64 73 74 76 78 77 70 
16 SURENDRAN 76 68 60 56 52 50 52 54 52 58 62 60 68 62 64 60 58 91 84 77 73 69 65 65 67 63 73 76 75 80 75 77 73 
17 SAKTHI 78 74 68 64 66 62 64 60 54 58 64 62 60 64 64 66 68 92 89 83 79 79 74 73 71 65 70 75 75 74 72 70 68 
18 KALPANA 84 78 72 70 64 68 62 66 58 52 60 58 60 58 64 66 68 93 91 84 82 75 77 71 75 67 65 76 73 74 72 77 78 
19 SEKAR 80 82 80 76 64 62 58 62 64 66 60 70 70 68 70 74 70 97 97 93 87 76 74 69 73 73 74 68 79 81 79 74 77 
20 PRABHU 68 62 56 52 50 48 60 58 54 60 64 62 66 64 66 68 64 87 81 74 69 66 62 72 70 65 71 74 75 78 77 72 74 
21 NATHAN 72 70 62 60 56 58 60 64 62 56 54 58 60 60 62 64 66 87 87 79 76 71 71 73 77 74 71 69 73 60 60 62 66 
22 SHAAHEERA 72 72 68 68 70 62 58 52 50 52 56 54 56 60 62 62 64 87 88 82 81 82 76 73 67 65 66 69 67 67 71 74 74 
23 RAJAN 68 64 62 60 56 56 60 58 52 54 56 60 62 62 64 66 68 85 83 81 79 75 73 75 73 69 70 71 74 76 77 76 76 
24 BABU 74 70 68 62 64 62 64 60 54 52 52 56 60 62 64 66 64 86 84 81 76 79 77 79 74 69 67 66 69 72 75 76 78 
25 MARIMUTHU 74 72 70 70 68 62 60 58 54 56 52 54 56 58 60 62 64 90 87 83 83 81 77 75 73 72 74 71 71 72 74 74 74 
26 SANTHANAM 78 72 68 62 64 68 70 62 68 62 60 64 66 68 68 70 68 93 89 84 78 79 81 82 76 81 75 73 75 75 74 73 70 
27 SHANTHI 70 68 60 60 62 60 62 60 56 58 64 66 62 64 66 66 68 84 83 77 76 77 75 76 74 71 72 77 78 74 75 76 75 
28 SRINIVASAN 70 70 68 62 56 52 50 50 52 56 58 60 64 60 62 58 62 84 85 82 77 72 69 66 64 65 68 69 72 75 74 75 70 
29 SHANKARI 86 84 76 74 70 68 62 56 56 52 58 60 62 54 56 58 62 97 96 91 89 84 82 77 73 73 69 73 73 74 70 74 73 
30 MUTHUKARIPPAN 68 70 64 72 68 64 64 66 62 60 60 62 64 64 66 64 62 89 89 84 89 82 79 79 79 75 73 74 74 75 76 81 80 
 
  
 
Patient GROUP A MAP_120m SpO2 base SpO2 1m SpO2 5m SpO2 10m SpO2 15M SpO2 20m SpO2 25m SpO2 30m SpO2 40m SpO2 50m SpO2 60m SpO2 70m SpO2 80m SpO2 90m SpO2 100 SpO2 110 SpO2 120 
1 EGAMBARAM 94 98% 98% 98 99 98 98 99 100 99 99 99 98 99 98 99 99 98 
2 GOPALAKRISHNAN 90 99 100 99 99 98 99 99 99 99 99 99 98 99 98 99 98 99 
3 DEVADARSAN 88 100 99 99 100 99 99 99 99 98 99 100 99 100 99 98 99 100 
4 MUNNUSAMY 84 99 98 99 98 99 99 99 98 98 98 98 99 99 99 99 99 99 
5 JAYAKODI 81 98 98 99 99 98 99 98 99 98 98 98 99 98 99 98 98 98 
6 DAMODARAN 86 99 99 99 98 99 98 98 98 98 98 98 99 99 98 98 98 98 
7 MEERA 77 100 99 100 99 100 100 99 99 99 98 99 100 99 99 99 99 99 
8 LAKSHMI 84 98 98 98 98 98 98 98 98 98 98 99 99 98 98 98 98 99 
9 BAKRUDDIN 85 99 98 99 98 99 98 99 98 99 98 99 98 99 99 99 98 99 
10 VADIVEL 86 100 100 99 100 100 99 100 100 99 99 98 99 100 99 100 99 100 
11 KAALI 78 99 98 99 98 99 98 99 99 99 99 100 99 100 99 100 99 99 
12 ARUL 86 99 98 99 99 99 99 99 99 99 99 99 99 99 98 99 98 99 
13 MOHAN 82 98 99 99 98 99 98 98 99 98 99 98 99 99 98 98 98 99 
14 JOTHI 80 99 98 99 99 99 99 99 99 99 98 99 99 99 98 99 99 98 
15 SUNDARAM 75 99 99 98 98 98 98 98 99 99 99 98 98 99 99 98 99 99 
16 DINESH 82 98 98 98 98 99 98 99 98 99 98 99 98 99 98 98 98 98 
17 MAHESHWARI 80 98 99 98 99 98 98 99 98 98 99 98 99 98 99 98 99 98 
18 ELUMALAI 80 99 98 98 98 98 99 98 98 98 98 98 98 98 98 98 99 99 
19 SAIRAM 77 98 99 98 99 98 98 99 98 98 98 99 98 98 98 98 98 99 
20 SEKAR 84 99 99 99 98 98 99 98 99 98 99 98 99 99 99 99 98 99 
21 SAMSON 84 98 98 99 98 99 98 99 98 98 98 98 99 98 99 98 99 98 
22 MAHALAKSHMI 80 99 100 99 100 100 99 100 99 100 99 99 99 100 100 99 100 99 
23 RAJESH 74 98 99 99 99 98 99 99 100 99 98 98 99 98 99 98 99 99 
24 KASTHURI 80 98 99 99 99 99 98 99 99 99 98 99 98 99 98 99 99 98 
25 SAKTHIVEL 72 98 99 98 99 98 99 99 98 98 99 98 98 99 99 99 98 98 
26 ANAND 78 99 99 99 98 98 99 98 99 99 98 98 99 99 98 99 98 99 
27 SUKUMAR 82 98 99 99 99 98 98 99 98 99 98 99 99 99 98 99 98 98 
28 GANESH 80 99 99 99 99 99 99 98 99 98 98 99 98 99 98 99 98 99 
29 SAIRABANU 80 98 99 98 99 98 99 98 99 98 99 98 99 98 98 98 98 98 
30 GOPI 76 99 98 98 99 98 99 98 98 98 98 98 98 98 98 98 98 98 
 GROUP B                   
1 BALAMURUGAN 90 99 99 99 98 98 98 99 98 99 98 98 98 98 98 98 98 99 
2 NIXON 84 98 99 98 98 99 99 99 98 99 99 98 99 98 99 98 99 98 
3 SURESH 88 99 98 99 98 99 98 98 99 99 99 98 98 99 98 99 98 99 
4 MURUGAN 80 98 99 99 98 98 98 99 99 98 99 98 99 98 98 99 98 99 
5 LAKSHMANAN 88 98 99 98 99 98 99 98 99 98 98 98 99 98 98 98 98 99 
6 RAVI 86 99 99 99 98 99 99 98 99 98 98 99 99 99 99 99 99 98 
7 THANUJA 77 99 98 98 98 99 98 99 98 99 98 98 98 99 98 98 98 98 
8 GOWRI 74 98 99 98 99 98 98 98 98 99 98 99 98 98 98 98 98 99 
9 SUKUMAR 80 99 98 98 99 99 98 99 98 99 98 99 98 98 99 98 99 99 
10 SHANKAR 74 98 98 98 99 98 99 98 99 98 99 98 98 98 98 98 99 98 
11 SHANMUGAM 76 99 99 98 99 98 99 98 99 98 98 99 98 98 99 98 99 98 
12 VENKATESAN 80 98 98 99 98 99 98 99 98 99 99 99 98 99 98 98 99 99 
13 SHAKTHI 74 99 99 98 98 99 99 99 98 99 98 99 98 99 99 98 98 98 
14 MALATHI 74 100 100 99 99 99 98 99 98 99 100 99 99 100 99 99 98 99 
15 VELMURUGAN 68 99 99 99 98 99 98 99 98 99 98 99 98 99 98 99 99 98 
16 SURENDRAN 72 99 98 99 98 99 98 99 99 99 98 99 98 99 99 98 98 98 
17 SAKTHI 70 99 99 99 98 99 99 98 99 98 99 98 99 99 98 99 98 99 
18 KALPANA 76 99 99 98 98 98 99 98 98 98 98 98 98 98 98 98 98 99 
19 SEKAR 76 98 98 98 98 99 98 98 98 99 99 99 98 98 99 98 99 98 
20 PRABHU 72 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 
21 NATHAN 64 99 98 99 98 99 99 98 99 98 99 98 99 99 99 99 99 98 
22 SHAAHEERA 75 98 98 98 98 99 98 99 98 99 98 99 98 99 98 99 98 98 
23 RAJAN 78 98 98 98 98 98 98 98 98 98 98 98 98 98 98 98 98 98 
24 BABU 74 98 99 99 99 98 98 98 99 98 99 98 99 98 99 98 99 98 
25 MARIMUTHU 70 98 99 99 99 98 99 98 99 98 99 98 98 98 99 99 98 99 
26 SANTHANAM 78 99 98 99 98 99 98 98 98 99 99 98 99 98 99 98 98 98 
27 SHANTHI 72 98 99 99 98 99 98 99 98 99 98 99 98 99 98 99 98 99 
28 SRINIVASAN 68 99 99 99 99 98 99 98 99 98 99 99 98 98 98 98 99 98 
29 SHANKARI 74 98 99 98 99 98 99 99 99 98 98 99 98 99 98 99 98 98 
30 MUTHUKARIPPAN 78 99 99 98 98 98 99 98 99 98 98 98 98 99 99 98 98 98 
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1 EGAMBARAM 78 78 76 80 82 84 88 110 114 112 118 116 110 112 64 62 64 70 72 74 76 79 79 80 86 86 86 88 99 98 99 98 99 99 98 
2 GOPALAKRISHNAN 70 74 76 78 78 80 84 120 116 122 114 120 122 124 70 72 74 76 78 76 78 87 87 90 89 92 91 93 99 98 99 99 98 99 99 
3 DEVADARSAN 80 82 84 84 86 82 84 130 132 124 128 126 120 122 68 66 64 70 72 74 76 89 88 84 89 90 89 91 98 98 99 98 99 98 98 
4 MUNNUSAMY 78 78 84 86 80 84 88 110 110 108 106 108 108 112 70 72 74 76 78 78 76 83 85 85 86 88 88 88 98 98 98 98 99 98 99 
5 JAYAKODI 80 80 82 84 86 86 84 120 122 124 122 120 110 118 66 68 66 70 74 76 74 84 86 85 87 89 87 89 99 99 98 99 98 99 98 
6 DAMODARAN 78 76 76 78 78 84 86 116 120 122 124 126 126 120 78 82 84 82 82 80 82 91 95 96 96 97 97 95 98 98 99 99 98 99 98 
7 MEERA 76 78 80 78 82 82 80 126 128 124 122 120 124 126 76 76 78 80 84 82 80 93 93 93 94 96 96 95 99 98 98 98 99 99 98 
8 LAKSHMI 78 78 78 82 84 84 86 120 116 114 110 110 116 124 82 84 86 86 84 86 84 95 95 95 94 93 96 97 99 98 98 98 99 98 99 
9 BAKRUDDIN 80 80 82 84 86 88 86 100 108 110 106 106 108 108 68 64 70 72 68 66 66 79 79 83 83 81 80 80 97 98 98 99 98 99 99 
10 VADIVEL 68 70 76 76 78 80 82 102 110 112 110 120 122 124 76 78 82 84 84 84 86 85 89 92 93 96 97 99 100 100 99 100 99 98 99 
11 KAALI 70 70 72 74 76 78 80 106 106 108 104 104 102 112 64 62 62 66 68 68 70 78 77 77 79 80 79 84 100 100 99 98 99 99 99 
12 ARUL 72 70 72 74 76 78 78 120 122 124 126 128 124 126 80 78 76 76 80 74 74 93 93 92 93 96 91 91 99 99 100 100 99 99 100 
13 MOHAN 80 82 84 86 84 84 86 114 116 110 112 110 112 116 70 70 68 72 70 72 76 85 85 82 85 83 85 89 99 99 98 99 99 98 99 
14 JOTHI 72 74 78 78 82 82 84 108 110 112 110 114 118 124 66 66 64 70 68 66 72 80 81 80 83 83 83 89 98 99 99 99 98 99 99 
15 SUNDARAM 78 78 84 82 86 88 86 126 134 132 130 134 130 134 72 74 76 76 78 78 76 90 94 95 94 97 95 95 100 100 99 99 100 99 100 
16 DINESH 80 86 82 84 86 86 88 132 134 136 132 128 126 128 80 82 80 82 80 84 86 97 99 99 99 96 98 100 99 99 100 100 100 99 100 
17 MAHESHWARI 72 78 76 74 76 78 80 128 124 126 128 124 126 122 80 82 86 88 86 84 84 96 96 99 101 99 98 97 100 100 100 99 99 99 100 
18 ELUMALAI 82 84 86 84 90 88 86 132 130 128 126 124 122 128 84 82 82 84 80 86 84 100 98 97 98 95 98 99 99 98 99 99 100 100 100 
19 SAIRAM 84 78 86 84 88 86 88 110 114 118 124 126 120 128 68 66 64 62 64 66 64 82 82 82 83 85 84 85 100 100 100 100 100 99 99 
20 SEKAR 80 84 82 84 88 86 88 126 124 124 126 124 122 126 74 76 78 76 74 78 80 91 92 93 93 91 93 95 98 99 99 98 99 98 99 
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21 SAMSON 78 74 76 80 78 82 84 118 120 118 124 124 128 126 72 68 74 76 78 76 74 87 85 89 92 93 93 91 100 100 100 99 99 99 98 
22 MAHALAKSHMI 82 86 84 86 88 82 88 124 126 124 124 122 124 124 76 74 78 79 80 82 82 92 91 93 94 94 96 96 99 100 99 100 99 99 99 
23 RAJESH 74 78 80 82 84 86 86 126 124 122 126 132 130 128 80 78 76 74 76 74 76 95 93 91 91 95 93 93 99 99 98 99 98 99 99 
24 KASTHURI 70 76 80 84 84 86 80 102 106 102 104 108 106 108 60 60 62 64 62 64 66 74 75 75 77 77 78 80 99 99 98 99 98 99 98 
25 SAKTHIVEL 72 76 78 80 84 86 86 118 122 122 126 124 124 124 70 72 74 76 74 78 76 86 89 90 93 91 93 92 99 98 99 99 99 98 99 
26 ANAND 78 76 84 88 86 82 84 116 110 112 110 114 116 118 76 78 84 82 80 82 80 89 89 93 91 91 93 93 99 98 98 98 98 99 98 
27 SUKUMAR 80 86 84 86 88 84 82 128 126 124 122 126 130 128 78 78 76 78 78 80 82 95 94 92 93 94 97 97 99 98 99 99 99 98 99 
28 GANESH 76 78 82 84 86 90 92 120 122 124 126 122 128 126 76 76 78 78 70 72 72 91 91 93 94 87 91 90 98 98 98 98 98 98 98 
29 SAIRABANU 64 66 68 66 68 70 74 114 118 116 116 114 120 124 78 76 72 74 70 72 72 90 90 87 88 85 88 89 99 99 99 99 99 98 98 
30 GOPI 74 70 74 76 80 84 86 116 120 122 124 122 120 126 72 74 76 70 72 74 70 87 89 91 88 89 89 89 98 98 98 98 98 98 99 
  GROUP B 
                                   
1 BALAMURUGAN 64 66 70 72 76 74 76 104 106 104 108 110 116 112 62 64 64 64 64 62 68 76 78 77 79 79 80 83 97 98 98 98 98 98 98 
2 NIXON 68 64 66 70 72 76 78 106 110 112 110 114 112 114 64 66 66 64 66 68 64 78 81 81 79 82 83 81 98 98 98 98 98 98 99 
3 SURESH 70 72 78 76 78 84 86 108 108 106 104 112 118 120 66 70 72 74 72 72 70 80 83 83 84 85 87 87 99 99 98 99 98 99 98 
4 MURUGAN 62 62 60 64 68 70 72 120 124 126 126 124 122 124 72 74 76 74 74 76 74 88 91 93 91 91 91 91 98 99 98 98 98 98 98 
5 LAKSHMANAN 68 72 74 76 72 72 70 126 124 124 122 120 124 122 68 66 64 68 66 64 68 87 85 84 86 84 84 86 98 98 98 98 98 98 98 
6 RAVI 68 70 70 72 74 78 72 118 116 110 120 122 120 122 70 72 74 76 72 72 74 86 87 86 91 89 88 90 99 99 98 98 98 98 98 
7 THANUJA 58 64 66 64 64 66 64 130 130 128 126 124 126 126 74 74 68 72 70 70 74 93 93 88 90 88 89 91 98 98 98 99 98 99 98 
8 GOWRI 62 64 66 64 64 66 62 128 124 124 126 128 126 130 66 62 64 66 62 68 66 87 83 84 86 84 87 87 99 98 99 100 100 98 99 
9 SUKUMAR 60 62 70 72 76 78 78 118 116 114 120 122 120 124 64 64 66 64 66 68 64 82 81 82 83 85 85 84 100 100 99 98 98 98 100 
10 SHANKAR 68 66 64 66 68 70 72 110 110 104 106 108 108 114 62 64 66 68 66 64 62 78 79 79 79 80 79 79 98 98 100 100 99 98 98 
11 SHANMUGAM 78 76 74 76 74 78 74 102 100 98 100 106 104 108 60 60 64 66 64 68 64 74 73 75 77 78 80 79 98 99 99 98 99 98 98 
12 VENKATESAN 80 78 78 82 82 80 82 106 112 116 114 112 108 110 64 62 64 62 66 66 68 78 79 78 79 81 80 82 100 100 100 100 99 98 99 
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13 SHAKTHI 64 66 68 72 70 72 74 98 102 104 102 104 102 110 60 62 64 68 66 64 68 73 75 77 79 79 77 82 100 99 100 99 98 98 99 
14 MALATHI 78 78 80 84 84 76 78 112 114 116 120 122 120 120 68 70 72 72 74 76 78 79 85 86 88 90 91 92 99 98 98 98 98 99 98 
15 VELMURUGAN 66 68 68 64 62 66 70 120 120 124 120 120 126 128 78 82 82 84 86 84 82 92 95 96 96 97 98 97 99 99 99 99 99 99 99 
16 SURENDRAN 62 60 74 74 74 76 78 108 114 118 120 122 126 124 68 66 64 68 72 74 76 81 82 82 85 89 91 92 98 98 98 98 98 98 98 
17 SAKTHI 66 60 62 64 68 70 74 124 124 122 122 124 126 122 72 74 76 78 74 76 74 89 91 91 93 91 93 90 98 98 98 98 98 99 99 
18 KALPANA 76 74 80 86 84 84 84 110 120 122 124 126 128 120 72 70 74 78 76 74 72 85 87 90 93 93 96 88 99 99 98 99 98 99 98 
19 SEKAR 78 76 77 78 71 70 69 96 100 104 106 110 112 110 62 64 66 68 70 72 72 73 76 79 81 83 85 85 99 98 99 98 99 98 99 
20 PRABHU 60 64 66 70 72 74 76 102 102 104 104 106 104 104 58 60 60 62 70 70 72 73 74 75 76 82 81 83 99 99 99 99 99 99 99 
21 NATHAN 60 64 64 66 68 66 70 106 106 108 110 106 112 116 74 74 68 70 72 72 72 85 85 81 83 83 85 87 98 98 98 98 98 98 98 
22 SHAAHEERA 68 62 64 74 72 74 76 118 110 114 120 120 122 128 76 70 72 74 76 74 74 90 83 86 89 91 90 92 100 100 99 100 100 100 100 
23 RAJAN 66 73 76 78 82 84 82 116 118 120 122 124 126 124 68 68 70 72 74 74 70 84 85 87 89 91 91 88 99 98 99 98 99 98 99 
24 BABU 74 76 78 74 72 72 70 110 110 118 120 122 120 118 66 62 64 64 66 68 66 81 78 82 83 85 85 83 99 99 99 99 99 99 99 
25 MARIMUTHU 70 72 76 80 78 84 84 120 122 124 126 122 124 120 80 82 84 86 84 82 80 93 95 97 99 97 96 93 99 100 99 100 99 99 99 
26 SANTHANAM 80 82 84 88 86 90 92 116 118 126 124 128 124 122 70 72 74 76 74 78 76 85 87 91 92 92 93 91 98 99 99 99 98 99 99 
27 SHANTHI 70 84 80 82 84 86 89 110 114 112 112 110 112 110 62 62 64 66 68 64 62 78 79 80 81 82 80 78 98 98 99 99 98 98 99 
28 SRINIVASAN 76 78 80 82 84 80 86 106 108 108 106 108 110 112 70 72 72 74 72 70 68 82 84 84 85 84 82 83 97 97 98 97 98 98 98 
29 SHANKARI 78 78 80 84 88 84 88 118 118 116 112 118 114 120 64 66 64 66 64 68 70 82 83 81 81 82 83 87 98 98 98 98 98 98 98 
30 MUTHUKARUPPAN 78 82 84 84 84 90 86 98 108 110 112 106 110 114 58 60 62 68 66 64 68 71 76 78 83 79 79 83 98 97 98 98 98 98 98 
 
